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Summary {#efs25069-sec-0001}
=======

This report of the European Food Safety Authority (EFSA) presents the detailed results of surveillance activities on animal transmissible spongiform encephalopathies (TSE) carried out during 2016 in the European Union (EU) and three non‐Member States (non‐MSs) as well as genotyping data in sheep. Summary statistics and trends are also presented covering the period between 2001 and 2016.

TSE monitoring data for bovine animals, small ruminants, cervids and species other than ruminants are reported by country according to Regulation (EC) 999/2001 (the TSE Regulation) and consist of testing data (reported monthly) as well as case data. Data regarding the genotyping of the ovine scrapie cases and of randomly selected sheep were retrieved from the annual reports submitted by the Member States (MSs) and non‐MSs in accordance with Article 6.4 of, and as specified in Chapter B.I of Annex III of the TSE Regulation.

A descriptive summary of the reported data is provided at MS level. Where possible, descriptions and calculations were stratified according to the available variables in the database, such as surveillance target group (healthy slaughtered animals, animals culled under bovine spongiform encephalopathy (BSE)/TSE control and eradication measures, etc.) or surveillance type (passive vs active), country, sampling year (since 2001 for bovine animals and 2002 for small ruminants), case type (i.e. classical BSE (C‐BSE), atypical BSE (H‐BSE or L‐BSE), classical scrapie (CS) or atypical scrapie (AS)), flock status (infected/non‐infected) and age class/group.

Since 2001, approximately 115 million cattle have been tested for BSE in the EU, with a sustained decrease in the number of animals tested over time following amendments to the TSE Regulation. The total number of samples tested for BSE in the EU fell from 1,442,446 in 2015 to 1,352,585 in 2016, representing a reduction of 5%. This was due to the decrease in the testing in the HS category (20% reduction from 491,052 in 2015 to 390,586 in 2016), mainly in three MSs: Germany, France and Poland. However, the number of samples tested from risk animals (AM + ES + FS) over 48 months of age showed an increase (+ 28,118) compared with 2015. In 2016, over 71% of all samples tested in the 31 reporting countries were from fallen stock.

In 2016, five BSE cases were detected in the EU, all among fallen stock, from two different MSs: France and Spain. One French case was of C‐BSE type, born after the reinforced EU‐wide feed ban imposed on 1 January 2001 (BARB case). The remaining four cases were of H‐BSE type: three in France and one in Spain. For the first time since BSE cases have been reported, no C‐BSE or atypical BSE cases were reported by the United Kingdom in 2016.

Since 2002, approximately 8.8 million small ruminants have been tested for scrapie in the EU. In 2016, a total of 286,351 sheep were tested, representing a decrease of 5%, compared with 2015. A total of 685 cases of scrapie in sheep were reported in the EU MSs: 554 of them were CS, 122 were AS and 9 were unknown type. CS was reported by nine different MSs, whereas AS cases were reported by 18 MSs. Most of the CS cases in sheep were detected in four MS: Greece (227), followed by Italy (143), Spain (91) and Romania (75). Portugal and Hungary are the MS with the largest number of AS cases reported: 28 and 23, respectively. In addition, 25 scrapie cases in sheep were reported by two non‐MSs: 11 CS cases in Iceland and 14 AS cases in Norway.

In 2016, a total of 110,832 goats were tested, representing a decrease of 11%, compared with 2015. A total of 634 cases of scrapie in goats were reported in the EU MSs: 621 of them were CS and 13 were AS. CS was reported by seven MSs with Cyprus accounting for 91.8% of all CS cases (570), followed by Spain (19 cases) and Greece (12 cases). AS was reported by five MSs, with Spain the country with the largest number of AS cases reported in goats: 5. Overall at the EU level, there is no consistent decline in the occurrence of scrapie in small ruminants, either in terms of the absolute number of cases or in the proportion of cases in tested animals.

A total of 97.2% of the CS cases in sheep reported in 2016 belonged to susceptible genotypes (NSP3, NSP3O, NSP4 or NSP5), and the genotyping data from random samples of the EU sheep population (excluding CY) showed that 26.6% of the genotyped sheep held genotypes of the susceptible group.

Chronic Wasting Disease (CWD) was confirmed for the first time in Europe in 2016, in Norway, where out of a total of 10,139 tested cervids five cases were reported: three in wild reindeer and two in moose. During the same period, 2,712 cervids were tested in seven different MSs and all were found negative. Most of the tested cervids (\> 90%) were reported by Romania. Four MSs tested for TSE 490 samples from animals of species other than ruminants and all were negative.

1. Introduction {#efs25069-sec-0003}
===============

1.1. Background and Terms of Reference {#efs25069-sec-0004}
--------------------------------------

According to Part I.A, Chapter B.I, Annex III of Regulation (EC) 999/2001[1](#efs25069-note-1005){ref-type="fn"} (hereinafter referred to as the transmissible spongiform encephalopathy (TSE) Regulation), the information to be presented by Member States (MSs) in their annual report, as provided for in Article 6(4), includes: The number of suspected cases placed under official movement restrictions in accordance with Article 12(1), per animal species.The number of suspected cases subject to laboratory examination in accordance with Article 12(2), per animal species, including the results of the rapid and confirmatory tests (number of positives and negatives) and, with regard to bovine animals, the age distribution of all tested animals. The age distribution should be grouped as follows: 'below 24 months', distribution per 12 months between 24 and 155 months, and 'above 155 months' of age.The number of flocks where suspected cases in ovine and caprine animals have been reported and investigated pursuant to Article 12(1) and (2).The number of bovine animals tested within each subpopulation referred to in Chapter A, Part I, points 2.1, 2.2, 3.1 and 5. The method of the sample selection, the results of the rapid and confirmatory tests and the age distribution of the tested animals grouped as set out in point 2 shall be provided.The number of ovine and caprine animals and flocks tested within each subpopulation referred to in Chapter A, Part II, points 2, 3, 5 and 6 together with the method for sample selection and the results of the rapid and confirmatory tests.The geographical distribution, including the country of origin if not the same as the reporting country, of positive cases of BSE and scrapie. The year, and where possible the month of birth shall be given for each TSE case in bovine, ovine and caprine animals. TSE cases that have been considered atypical shall be indicated. For scrapie cases, the results of the primary and secondary molecular testing, referred to in Annex X, Chapter C, point 3.2(c), shall be reported, where appropriate.In animals other than bovine, ovine and caprine animals, the number of samples and confirmed TSE cases per species.The genotype, and, where possible, the breed, of each ovine animal either found positive for TSE and sampled in accordance with Chapter A, Part II, point 8.1, or sampled in accordance with Chapter A, Part II, point 8.2.

According to Chapter B.II, 'the compilation of reports containing the information referred to in B.I and submitted to the Commission (which shall send it to the European Food Safety Authority) on a monthly basis in the electronic format agreed between the MSs, the Commission and the European Food Safety Authority or, with regard to the information referred to in point 8 on a quarterly basis, may constitute the annual report as required by Article 6(4), provided that the information is updated whenever additional information becomes available'.

The Union summary shall be presented in a tabled format covering at least the information referred to in Part I.A Chapter B.I for each MS.

1.2. Surveillance of TSE in the European Union {#efs25069-sec-0005}
----------------------------------------------

### 1.2.1. Legal basis {#efs25069-sec-0006}

Animals suspected of a TSE should be examined in accordance with Article 12.2 of the TSE Regulation. The legal framework for the active monitoring of ruminants for the presence of TSE is laid down in Article 6 of the TSE Regulation, and specified in its Annex III, Chapter A.

Of the 27 MSs at that time, Commission Decision 2009/719/EC[2](#efs25069-note-1102){ref-type="fn"}, allowed 25 (all except Bulgaria and Romania) to apply a revised bovine spongiform encephalopathy (BSE) monitoring programme. Commission Implementing Decision 2013/76/EU[3](#efs25069-note-1006){ref-type="fn"} of 4 February 2013, amending Commission Decision 2009/719/EC, authorised these 25 MSs to decide to stop testing slaughtered bovine animals that had been healthy.

Commission Decision 2016/851 of 26 May 2016 authorised the revision of the Croatian BSE annual monitoring programme under the same conditions as granted to the 25 MSs currently listed in the Annex to Decision 2009/719/EC[4](#efs25069-note-1104){ref-type="fn"}.

The legal basis for the sample collection and for the test methods is laid down in Chapter C of Annex X of the TSE Regulation. From 2005, Annex X (as amended by Commission Regulation (EC) No 36/2005[5](#efs25069-note-1007){ref-type="fn"}) also provides for mandatory discriminatory testing for BSE of TSE cases detected in small ruminants.

The legal basis for the testing for the determination of the prion protein genotypes (genotype testing) is laid down in points 8.1 and 8.2 of Chapter A in Annex III of the TSE Regulation.

### 1.2.2. BSE surveillance of bovine animals {#efs25069-sec-0007}

The BSE surveillance of bovine animals is based on the testing of samples from the following target groups: **Animals clinically suspected of being infected by BSE (SU):** live, slaughtered or dead animals that show or have shown neurological or behavioural disorders or a progressive deterioration of the general condition linked to impairment of the central nervous system and for which the information gathered on the basis of a clinical examination, response to treatment, a post‐mortem examination or *ante*‐ or *post‐mortem* laboratory analysis does not allow an alternative diagnosis to be established. BSE shall be suspected in bovine animals that have produced a positive result from a rapid test specifically for BSE as defined in Article 3.1(h) of the TSE Regulation and subject to the measures described in Articles 12 and 13.**Animals culled under BSE eradication measures (EM):** birth cohorts (bovine animals born in the same herd as the affected bovine animal within the 12 months preceding or following the date of birth of the affected bovine animal), rearing cohorts (bovine animals that at any time during the first year of their lives were reared together with the affected bovine animal during the first year of its life) (point 2, Annex I) and, where the disease was confirmed in a female animal, its progeny born within a period of 2 years prior to or after the clinical onset of the disease (point 1(a) Chapter B, Annex VII).**Animals with clinical signs at** ***ante‐mortem*** **(AM):** bovine animals with (abnormal) observations at *ante‐mortem* inspections (Article 6 1a(a)).**Emergency slaughtered (ES):** bovine animals sent for emergency slaughter (Article 6.1a(a)).**Fallen stock (FS):** bovine animals not slaughtered for human consumption that have died or been killed on the farm, during transport or in an abattoir (Article 6 1a(c)). (MSs may decide to derogate from this provision in remote areas with low animal density, where no collection of dead animals is organised). The derogation shall not cover more than 10% of the bovine population in the MSs.**Healthy slaughtered (HS):** bovine animals slaughtered for human consumption (Article 6.1a(b)).

The categories of bovine animals to be submitted for BSE testing are defined in the TSE Regulation and are based on a combination of age (limits) and surveillance target groups. The general rules for BSE surveillance, applied in 2016, are summarised in Table [1](#efs25069-tbl-0001){ref-type="table"}. The age limits, to be applied for certain surveillance target groups, have been changed over time. In most of the countries, the testing age limit for the healthy slaughtered category has been shifted from 30 to 48 months in 2009, and to 72 months in 2011. Based on the revision of the testing regimes provided by Decision 2009/719/EC, the testing of HS has been discontinued by most of the MSs. Regarding the risk categories (i.e. FS, ES, AM), one shift from 24 to 48 months was enforced in 2009. A table summarising the evolution of the changes was published in the 2015 EU Summary Report.[6](#efs25069-note-1008){ref-type="fn"}

However, there are still some differences in the application of these general rules owing to specific national rules that provide some residual testing of HS or the testing of younger at‐risk animals. These national rules, as applied in 2016, are shown in Table [2](#efs25069-tbl-0002){ref-type="table"}.

###### 

Criteria for BSE surveillance in bovine animals as applied in 2016 by country, age limit and surveillance target group, based on the TSE Regulation (EC) as amended and Commission Implementing Decision 2013/76/EU of 4 February 2013

                                                                                                             EU 26                           Romania, Bulgaria[a](#efs25069-note-0006){ref-type="fn"}
  ---------------------------------------------------------------------------------------------------------- ------------------------------- ----------------------------------------------------------
  Animals with clinical signs at *ante‐mortem* (AM); Emergency slaughtered animals (ES); Fallen stock (FS)   \> 48 months                    \> 24 months
  Healthy slaughtered animals (HS)                                                                           No mandatory testing required   \> 30 months
  Animal culled under BSE eradication measures (EM) BSE suspects (SU)                                        All                             All

BSE: bovine spongiform encephalopathy.

Different criteria were applied in 2016 because Bulgaria and Romania were not in the list of the 26 Member States authorised at that time to revise their BSE annual surveillance programmes according to Commission Implementing Decision 2013/76/EU of 4 February 2013.

John Wiley & Sons, Ltd

###### 

Age limits (in months) of bovine animals tested for BSE surveillance applied in 2016 by Member States and Norway and surveillance target group

  Member state   Surveillance target group                                                                                                                                    
  -------------- --------------------------- ---------------------------------------------- ------- ------- ----------------------------------------------------------------- --------------
  AT             No age limit                \> 48[a](#efs25069-note-0009){ref-type="fn"}   \> 24   \> 24   No testing                                                        No age limit
  BE             No age limit                \> 48                                          \> 48   \> 48   No testing                                                        \> 24
  BG             No age limit                \> 24                                          \> 24   \> 24   \> 30                                                             No age limit
  CY             No age limit                \> 48                                          \> 48   \> 48   No testing                                                        \> 48
  CZ             No age limit                \> 24                                          \> 24   \> 24   No testing                                                        No age limit
  DE             No age limit                \> 48                                          \> 48   \> 48   No testing                                                        No age limit
  DK             No age limit                \> 48                                          \> 48   \> 48   No testing                                                        \> 48
  EE             No age limit                \> 48                                          \> 48   \> 48   No testing                                                        No age limit
  EL             No age limit                \> 48                                          \> 48   \> 48   \> 72                                                             No age limit
  ES             No age limit                \> 48                                          \> 48   \> 48   Born before 2001 and coming from flocks with BSE positive cases   No age limit
  FI             No age limit                \> 48                                          \> 48   \> 48   No testing                                                        No age limit
  FR             No age limit                \> 24                                          \> 24   \> 24   Born before 1/1/2002                                              \> 24
  HR             No age limit                \> 48[b](#efs25069-note-0010){ref-type="fn"}   \> 48   \> 48   No testing                                                        No age limit
  HU             No age limit                \> 24                                          \> 24   \> 24   No testing                                                        No age limit
  IE             No age limit                \> 48                                          \> 48   \> 48   No testing                                                        \> 48
  IT             No age limit                \> 48                                          \> 48   \> 48   No testing                                                        No age limit
  LT             No age limit                \> 48                                          \> 48   \> 48   No testing                                                        No age limit
  LU             No age limit                \> 48                                          \> 48   \> 48   No testing                                                        \> 48
  LV             No age limit                \> 24                                          \> 24   \> 24   No testing                                                        No age limit
  MT             No age limit                \> 48                                          \> 48   \> 48   No testing                                                        No age limit
  NL             No age limit                \> 48                                          \> 48   \> 48   No testing                                                        No age limit
  PL             No age limit                \> 48                                          \> 48   \> 48   \> 108                                                            No age limit
  PT             No age limit                \> 48                                          \> 48   \> 48   No testing                                                        No age limit
  RO             No age limit                \> 24                                          \> 24   \> 24   \> 30                                                             No age limit
  SE             No age limit                \> 48                                          \> 48   \> 48   No testing                                                        No age limit
  SI             No age limit                \> 24                                          \> 24   \> 24   No testing                                                        No age limit
  SK             No age limit                \> 24                                          \> 24   \> 24   No testing                                                        No age limit
  UK             No age limit                \> 48                                          \> 48   \> 48   No testing                                                        No age limit
  NO             No age limit                \> 48                                          \> 48   \> 48   No testing                                                        No age limit

SU: Animals clinically suspected of being infected with BSE; FS: fallen stock; ES: emergency slaughtered; AM: animals with clinical signs at *ante‐mortem*; HS: healthy slaughtered; EM: animals culled under BSE eradication measures.

If surveillance target group is FS and animals are born in Romania, Bulgaria or Croatia the age limit is \> 24. In particular for Croatia, the age limit of \> 24 months for animals from FS was applied until the end of May 2016 as the Commission Implementing Decision (EU) 2016/851 changed this age limit to \> 48 months from June 2016 onwards.

Age limits are expressed in months.

The limits have been revised after the publication the Commission Decision 2016/851 of 26 May 2016.

John Wiley & Sons, Ltd

#### 1.2.2.1. Testing protocol for BSE surveillance in bovine animals {#efs25069-sec-0008}

All samples intended to be examined for the presence of TSE shall in general be collected using the methods and protocols laid down in the latest edition of the *Manual for Diagnostic Tests and Vaccines for Terrestrial Animals* of the World Organisation for Animal Health (OIE).

Samples from bovine animals sent for laboratory testing pursuant to the provisions of Annex III, Chapter A, Part I shall be examined with a rapid test. When the result of the rapid test is inconclusive or positive, the sample shall immediately be subjected to confirmatory examinations using at least one of the following methods and protocols laid down in the latest edition of the Manual (Figure [1](#efs25069-fig-0001){ref-type="fig"}).

Samples from bovine animals collected from suspect cases should be subjected to confirmatory examinations using at least one of the following methods: immunohistochemistry (IHC), western Blot (WB), demonstration of characteristic scrapie‐associated fibrils (SAF) by electron microscopy, or histopathological examination and a combination of rapid tests. Rapid tests may be used for both primary screening and, if inconclusive or positive, subsequent confirmation according to the guidelines from the European Union TSE Reference Laboratory (EURL).

According to point 3.1(b), Chapter C, Annex X, where the result of the primary screening is not confirmed by the subsequent rapid test, the sample must be subjected to an examination using one of the other confirmatory methods. Where histopathological examination is used for that purpose but proves to be inconclusive or negative, the tissues must be submitted for further examination using one of the other confirmatory methods and protocols.

![TSE testing protocol for bovine animals\
(a): Animals clinically suspected of being infected by BSE should be immediately subjected to confirmatory examinations. (b): If histopathology is negative or inconclusive or if there is a discrepancy between rapid tests, a new examination with another confirmatory method is needed.](EFS2-15-e05069-g001){#efs25069-fig-0001}

Samples from all positive BSE cases should be forwarded to a laboratory for discriminatory testing of confirmed BSE cases, for the classification of bovine TSE isolates in C‐BSE, L‐BSE and H‐BSE; according to point 3.1(a)(c), Chapter C, Annex X of the TSE Regulation, as amended by Commission regulation 630/2013[7](#efs25069-note-1009){ref-type="fn"}.

### 1.2.3. TSE[8](#efs25069-note-1010){ref-type="fn"} surveillance of small ruminants {#efs25069-sec-0009}

The surveillance of ovine and caprine animals for the presence of TSE is performed based on testing samples obtained from the following surveillance target groups: **Animals clinically suspected of being infected by TSE (SU):** ovine and caprine live, slaughtered or dead animals that show or have shown neurological or behavioural disorders or a progressive deterioration of their general condition linked to impairment of the central nervous system and for which the information gathered on the basis of a clinical examination, response to treatment, a post‐mortem examination or an *ante*‐ or *post‐mortem* laboratory analysis does not allow an alternative diagnosis to be established (Article 3.1(h)of the TSE Regulation) and subject to the measures described in Articles 12 and 13 of the TSE Regulation.**Animals culled under TSE eradication measures (EM):** in a TSE‐infected flock or herd where BSE cannot be excluded, all animals, embryos and ova identified by the inquiry shall be killed and completely destroyed, without delay. When BSE and atypical scrapie (AS) can be excluded and option 1 (killing and complete destruction or slaughtered for human consumption of all animals) has been applied, animals over 18 months of age that are killed for destruction shall be tested for the presence of TSE based on the selection of a simple random sample, in accordance with the sample size set in Annex III, Chapter A, Section II, point 5. If derogations for killing and destruction are applied, all animals that are over 18 months of age slaughtered for human consumption shall be tested. When option 2 is applied (killing and complete destruction or slaughter for human consumption of the susceptible animals only), after the genotyping of all ovine animals, a simple random sample of the animals over 18 months of age selected for killing and destruction shall be tested for the presence of TSE in accordance with the sample size set in Annex III, Chapter A, Section II, point 5. If derogations for killing and destruction are applied, all animals that are over 18 months of age and slaughtered for human consumption shall be tested.**Animals not slaughtered for human consumption (NSHC):** ovine and caprine animals that have died or been killed, but which were not killed in the framework of a disease eradication campaign or slaughtered for human consumption. Minimum sample sizes are set (according Table A of Annex III, Chapter A, Section II, point 3) to take into account the size of the ovine populations in the individual MSs and are intended to provide achievable targets (Table [4](#efs25069-tbl-0004){ref-type="table"}).In the case of an infected flock or herd where either option 2 or 3 or derogations (points 2.2.2(c) i) and ii)) have been applied, and during the 2‐year intensified TSE testing programme or for a period of 2 years from the date of the detection of the last classical scrapie (CS) case, all animals (except ARR/ARR ovine animals) over the age of 18 months that have died or been killed on the holding but were not killed in the framework of a disease eradication campaign must be tested for the presence of TSE.In the case of an infected flock or herd where option 2 is applied but with a delayed killing and destruction or slaughtering for human consumption of susceptible animals (derogation point 2.2.2.(c)(iii)), during the period of delay (between the detection of the CS case and the complete killing and destruction or slaughtering of susceptible animals), all animals (except ARR/ARR ovine animals) over the age of 18 months which have died or been killed on the holding but which were not killed in the framework of a disease eradication campaign must be tested for the presence of TSE. Furthermore, after the killing and destruction or slaughtering of susceptible animals, a 2‐year intensified TSE testing programme must be carried out or a programme for 2 years from the date of the detection of the last CS case, all animals (except ARR/ARR ovine animals) over the age of 18 months which have died or been killed on the holding but which were not killed in the framework of a disease eradication campaign must be tested for the presence of TSE.**Healthy animals slaughtered for human consumption (SHC):** MSs in which the population of ewes and ewe lambs put to the ram, in the case of sheep, or the population of goats that have already kidded and goats mated exceeds 750,000 animals, shall test a minimum annual sample of 10,000 ovine and/or caprine animals slaughtered for human consumption (point 2(a), Section II, Chapter A, Annex III of the TSE Regulation) (see Table [4](#efs25069-tbl-0004){ref-type="table"}). MSs may choose to replace a maximum of 50% of their minimum sample size of ovine and caprine animals slaughtered for human consumption by testing dead ovine or caprine animals over the age of 18 months and a maximum of 10% of their minimum sample size of SHC and NSHC by testing ovine or caprine animals killed in the framework of a disease eradication campaign over the age of 18 months at a ratio of one to one.In the case of an infected flock or herd where option 2 or derogations (point 2.2.2(c) i) and ii)) has been applied, and during the intensified TSE testing programme for a period of 2 years or from the date of the detection of the last CS case, animals that were kept in the holding at the time when the TSE case was confirmed and that have been slaughtered for human consumption shall be tested for TSE.In the case of an infected flock where option 3 (no mandatory killing and complete destruction of animals) have been applied, and during the intensified TSE testing programme for a period of 2 years from the date of the detection of the last CS case, all of the animals which are over the age of 18 months (except ARR/ARR animals) which have been slaughtered for human consumption shall be tested for the presence of TSE.In the case of an infected flock or herd where option 2 is applied but with a delayed killing and destruction or slaughtering for human consumption of susceptible animals (derogation 2.2.2.(c)(iii)), during the period of delay (between the detection of the CS case and the complete killing and destruction or slaughtering of susceptible animals), all animals (except ARR/ARR ovine animals) over the age of 18 months which are slaughtered for human consumption must be tested for the presence of TSE. Furthermore, after the killing and destruction or slaughtering of susceptible animals, a 2‐year intensified TSE testing programme must be carried out or a programme for 2 years from the date of the detection of the last CS case, and all animals (except ARR/ARR ovine animals) over the age of 18 months which were kept at the holding at the time when the TSE case was confirmed, and which are slaughtered for human consumption, must be tested for the presence of TSE.

Where the TSE case confirmed in a holding is an AS case, the holding shall be subject to the following intensified TSE surveillance protocol for a period of 2 years from the date of detection of the last AS case: all ovine and caprine animals that are over the age of 18 months and slaughtered for human consumption, and all ovine and caprine animals over the age of 18 months that have died or been killed on the holding shall be tested for the presence of TSE. If a case of TSE, other than AS, is confirmed during the intensified TSE monitoring period of two years, the holding shall be subjected to measures laid down in points 2.2.1 and 2.2.2 of Annex VII, Chapter B, Part II.

The above classification of surveillance target groups has been used to outline the data in this report and to summarise historical data, as shown in Table [3](#efs25069-tbl-0003){ref-type="table"}.

###### 

Target surveillance groups in small ruminants to be reported for surveillance for TSE based on the infection status of flock/herd/holding, the case type detected and the control measures taken according the TSE regulation

+------------------------------------------------------------------------------------------------------------------------------------------+------------+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+
| Reported flock status                                                                                                                    | Index case | Case type | Control measures taken                                                                                                                                                                                                                                                                                                | Sampled population                                                                                                                   | Surveillance target group to be reported |
+==========================================================================================================================================+============+===========+=======================================================================================================================================================================================================================================================================================================================+======================================================================================================================================+==========================================+
| Non‐infected flock[a](#efs25069-note-0013){ref-type="fn"}                                                                                | Yes        | CS or AS  | n/a                                                                                                                                                                                                                                                                                                                   | Slaughtered for human consumption. Annex III, Chapter A, Part II, point 2                                                            | **SHC**                                  |
+------------------------------------------------------------------------------------------------------------------------------------------+------------+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+
| Not slaughtered for human consumption. Annex III, Chapter A, Part II, point 3                                                            | **NSHC**   |           |                                                                                                                                                                                                                                                                                                                       |                                                                                                                                      |                                          |
+------------------------------------------------------------------------------------------------------------------------------------------+------------+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+
| TSE suspects                                                                                                                             | **SU**     |           |                                                                                                                                                                                                                                                                                                                       |                                                                                                                                      |                                          |
+------------------------------------------------------------------------------------------------------------------------------------------+------------+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+
| TSE‐infected flock under official control at sampling[b](#efs25069-note-0014){ref-type="fn"}                                             | No         | CS        | Killing and complete destruction of all animals (option 1) Annex VII, Chapter B, point 2.2.2 [b](#efs25069-note-0014){ref-type="fn"} or killing and complete destruction of the susceptible animals only (option 2) Annex VII, Chapter B, point 2.2.2 (c)                                                             | Culled and destroyed under options 1 or 2                                                                                            | **EM**                                   |
+------------------------------------------------------------------------------------------------------------------------------------------+------------+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+
| Slaughtered for human consumption after application of option 1 or option 2 [a](#efs25069-note-0013){ref-type="fn"}                      | **SHC**    |           |                                                                                                                                                                                                                                                                                                                       |                                                                                                                                      |                                          |
+------------------------------------------------------------------------------------------------------------------------------------------+------------+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+
| TSE clinical suspects Chapter 4, Article 12, points 1--2                                                                                 | **SU**     |           |                                                                                                                                                                                                                                                                                                                       |                                                                                                                                      |                                          |
+------------------------------------------------------------------------------------------------------------------------------------------+------------+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+
| TSE‐infected flock under official control at sampling[b](#efs25069-note-0014){ref-type="fn"}                                             | No         | CS        | Follow‐up after implementation of control measures according to Annex VII, point 2. Intensified TSE monitoring protocol (Annex VII, point 3) after option 1 or option 2, or in case of derogation of option 2 was established, after complete destruction or slaughtering for human consumption of identified animals | Slaughtered for human consumption point 3.1.[a](#efs25069-note-0013){ref-type="fn"}                                                  | **SHC**                                  |
+------------------------------------------------------------------------------------------------------------------------------------------+------------+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+
| Not Slaughtered for human consumption point 3.1.[b](#efs25069-note-0014){ref-type="fn"}                                                  | **NSHC**   |           |                                                                                                                                                                                                                                                                                                                       |                                                                                                                                      |                                          |
+------------------------------------------------------------------------------------------------------------------------------------------+------------+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+
| TSE clinical suspects Chapter 4, Article 12, points 1--2                                                                                 | **SU**     |           |                                                                                                                                                                                                                                                                                                                       |                                                                                                                                      |                                          |
+------------------------------------------------------------------------------------------------------------------------------------------+------------+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+
| TSE‐infected flock under official control at sampling[b](#efs25069-note-0014){ref-type="fn"}                                             | No         | CS        | Follow‐up after implementation of control measures according to Annex VII, point 2                                                                                                                                                                                                                                    | Slaughtered for human consumption point 4.1.[a](#efs25069-note-0013){ref-type="fn"}                                                  | **SHC**                                  |
|                                                                                                                                          |            |           |                                                                                                                                                                                                                                                                                                                       |                                                                                                                                      |                                          |
|                                                                                                                                          |            |           | Intensified TSE monitoring protocol (Annex VII, point 4) after option 3                                                                                                                                                                                                                                               |                                                                                                                                      |                                          |
+------------------------------------------------------------------------------------------------------------------------------------------+------------+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+
| Not Slaughtered for human consumption point 4.1. [b](#efs25069-note-0014){ref-type="fn"}                                                 | **NSHC**   |           |                                                                                                                                                                                                                                                                                                                       |                                                                                                                                      |                                          |
+------------------------------------------------------------------------------------------------------------------------------------------+------------+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+
| TSE clinical suspects Chapter 4, Article 12, points 1--2                                                                                 | **SU**     |           |                                                                                                                                                                                                                                                                                                                       |                                                                                                                                      |                                          |
+------------------------------------------------------------------------------------------------------------------------------------------+------------+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+
| TSE‐infected flock under official control at sampling[b](#efs25069-note-0014){ref-type="fn"}                                             | No         | CS        | Intensified TSE monitoring protocol pending the implementation of control measures according to the derogation in point 2.2.2.(c)(iii) and after the implementation of the control measures                                                                                                                           | Slaughtered for human consumption. Point 4.1.[a](#efs25069-note-0013){ref-type="fn"} and 3.1.[a](#efs25069-note-0013){ref-type="fn"} | **SHC**                                  |
+------------------------------------------------------------------------------------------------------------------------------------------+------------+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+
| Not Slaughtered for human consumption. Point 4.1.[b](#efs25069-note-0014){ref-type="fn"} and 3.1.[a](#efs25069-note-0013){ref-type="fn"} | **NSHC**   |           |                                                                                                                                                                                                                                                                                                                       |                                                                                                                                      |                                          |
+------------------------------------------------------------------------------------------------------------------------------------------+------------+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+
| TSE clinical suspects. Chapter 4, Article 12, points 1--2                                                                                | **SU**     |           |                                                                                                                                                                                                                                                                                                                       |                                                                                                                                      |                                          |
+------------------------------------------------------------------------------------------------------------------------------------------+------------+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+
| TSE‐infected flock under official control at sampling[b](#efs25069-note-0014){ref-type="fn"}                                             | No         | AS        | Intensified TSE monitoring protocol after the detection of an Atypical Scrapie case (Annex VII point 2.2.3)                                                                                                                                                                                                           | Slaughtered for human consumption point 2.2.3                                                                                        | **SHC**                                  |
+------------------------------------------------------------------------------------------------------------------------------------------+------------+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+
| Not slaughtered for human consumption point 2.2.3                                                                                        | **NSHC**   |           |                                                                                                                                                                                                                                                                                                                       |                                                                                                                                      |                                          |
+------------------------------------------------------------------------------------------------------------------------------------------+------------+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+
| TSE clinical suspects Chapter 4, Article 12, points 1--2                                                                                 | **SU**     |           |                                                                                                                                                                                                                                                                                                                       |                                                                                                                                      |                                          |
+------------------------------------------------------------------------------------------------------------------------------------------+------------+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+

Option 2 can only be applied to sheep (genotyping and culling).

EM: Animals culled under TSE eradication measures; NSHC: Animals not slaughtered for human consumption; SHC: animals slaughtered for human consumption SU: Animals clinically suspected of being infected by TSE.

Sheep flocks or goat herds that are not under control measures or intensified TSE protocols or a sheep flock or goat herd that has never been infected with scrapie and for which every new detected case will be an index case.

Sheep flocks or goat herds that are under control measures or intensified TSE protocols or a sheep flock or goat herd that has been infected during reporting year.

John Wiley & Sons, Ltd

###### 

Minimum testing requirements for the TSE surveillance in small ruminants by Member State in 2016

  Member State   Sheep      Goats                                         
  -------------- ---------- -------- ---------------- ---------- -------- ----------------
  AT             100--750   0        1,500            40--250    0        100% up to 500
  BE             100--750   0        1,500            40--250    0        100% up to 500
  BG             \> 750     10,000   10,000           40--250    0        100% up to 500
  CY             100--750   0        1,500            40--250    0        100% up to 500
  CZ             100--750   0        1,500            \< 40      0        100% up to 100
  DE             \> 750     10,000   10,000           40--250    0        100% up to 500
  DK             40--100    0        100% up to 500   \< 40      0        100% up to 100
  EE             40--100    0        100% up to 500   \< 40      0        100% up to 100
  EL             \> 750     10,000   10,000           \> 750     10,000   10,000
  ES             \> 750     10,000   10,000           \> 750     10,000   10,000
  FI             40--100    0        100% up to 500   \< 40      0        100% up to 100
  FR             \> 750     10,000   10,000           \> 750     10,000   10,000
  HR             100--750   0        1,500            40--250    0        100% up to 500
  HU             \> 750     10,000   10,000           \< 40      0        100% up to 100
  IE             \> 750     10,000   10,000           \< 40      0        100% up to 100
  IT             \> 750     10,000   10,000           \> 750     10,000   10,000
  LT             40--100    0        100% up to 500   \< 40      0        100% up to 100
  LU             \< 40      0        100% up to 100   \< 40      0        100% up to 100
  LV             \< 40      0        100% up to 100   \< 40      0        100% up to 100
  MT             \< 40      0        100% up to 100   \< 40      0        100% up to 100
  NL             100--750   0        1,500            250--750   0        1,500
  PL             100--750   0        1,500            \< 40      0        100% up to 100
  PT             \> 750     10,000   10,000           250--750   0        1,500
  RO             \> 750     10,000   10,000           \> 750     10,000   10,000
  SE             100--750   0        1,500            \< 40      0        100% up to 100
  SI             40--100    0        100% up to 500   \< 40      0        100% up to 100
  SK             100--750   0        1,500            \< 40      0        100% up to 100
  UK             \> 750     10,000   10,000           40--250    0        100% up to 500
  NO             \> 750     10,000   10,000           40--250    0        100% up to 500

NSHC: Animals not slaughtered for human consumption; SHC: animals slaughtered for human consumption.

Norway tested according a population (thousand head) of \> 750 and 40--250 in sheep and goats, respectively.

Thousand head.

John Wiley & Sons, Ltd

#### 1.2.3.1. Testing protocols for TSE surveillance in small ruminants {#efs25069-sec-0010}

Samples from ovine and caprine animals sent for laboratory testing pursuant to the provisions of Annex III, Chapter A, Part II (Monitoring in ovine and caprine animals) shall be examined with a rapid test to ensure the detection of all known strains of TSE. When the result of the rapid test is inconclusive or positive, the sampled tissues shall immediately be sent to an official laboratory for confirmatory examinations by histopathology, IHC, WB or characterisation of SAF by electron microscopy, as referred to in point (a) of Annex X, Chapter C, Point 3.2. If the result of the confirmatory examination is negative or inconclusive, the tissues shall be submitted for further examination by IHC or WB. If the result of one of the confirmatory examinations is positive, the animal shall be regarded as a positive TSE case and further examination as referred to in point (c) of Annex X, Chapter C, Point 3.2 shall be performed (Figure [2](#efs25069-fig-0002){ref-type="fig"}).

Samples from ovine or caprine animals collected from suspect cases should immediately be subjected to confirmatory examinations using at least one of the following methods: IHC, WB, demonstration of characteristic SAF by electron microscopy or histopathological examination. Samples from routine monitoring should be examined using a rapid test to ensure the detection of all known strains of TSE.

According to point 3.2(b), Chapter C, Annex X, when the result of the rapid test is inconclusive or positive, the sampled tissues should be immediately sent to an official laboratory for confirmatory examinations by histopathology, IHC, WB or SAF. If the result of the confirmatory examination is negative or inconclusive, the tissues should be submitted for further examination by IHC or WB.

Samples from clinical suspect cases and from animals tested in accordance with Annex III, Chapter A, Part II, points 2 and 3 which are regarded as positive TSE cases but which are not AS cases or that display characteristics deemed by the testing laboratory to merit investigation, shall be examined using a discriminatory WB method listed in the guidelines of the TSE EURL by an official diagnostic laboratory designated by the competent authority (point 3.2(c), Chapter C, Annex X). TSE cases in which the presence of BSE cannot be excluded by the primary molecular testing should be submitted for further investigation and confirmation using at least one alternative method differing immunochemically from the original primary molecular method.

![Testing protocol for small ruminants\
(a): Suspect cases will be immediately subjected to confirmatory examinations.(b): If histopathology is negative or inconclusive, further examination using another confirmatory method is needed.(c): Primary molecular test using discriminatory WB assays performed in National Reference Laboratories (NRL) or the TSE EURL.(d): Secondary molecular testing (repeat WB assays, discriminatory enzyme‐linked immunosorbent assay (ELISA) and IHC) and possibly a mouse bioassay must be conducted in the EURL.](EFS2-15-e05069-g002){#efs25069-fig-0002}

#### 1.2.3.2. Genotyping in sheep {#efs25069-sec-0011}

The prion protein genotype for codons 136,154 and 171 shall be determined for each positive TSE case in sheep (point 8.1, Section II, Chapter A, Annex III). In addition, the prion protein genotype for the codons 136, 141, 154 and 171 of a minimum sample of ovine animals should be determined. In the case of MSs with an adult sheep population of \> 750,000 animals, this minimum sample should be at least 600 animals. In the case of other MSs, the minimum sample should be at least 100 animals. The samples may be chosen from animals slaughtered for human consumption, from dead‐on‐farm animals or from live animals. The sampling should be representative of the entire ovine population (point 8.2, Section II, Chapter A, Annex III).

### 1.2.4. TSE surveillance in other species (CWD surveillance of cervids) {#efs25069-sec-0012}

MSs are obliged according Article 6(4) of the TSE Regulation to report the number of samples tested and the number of confirmed TSE cases for species other than bovine, ovine and caprine animals. For the reporting on chronic wasting Disease (CWD) in cervids, a new electronic data submission form was prepared in 2016. Separate summary data for surveillance of CWD in cervids is presented in this report.

2. Data and methods {#efs25069-sec-0013}
===================

2.1. Origin of the data {#efs25069-sec-0014}
-----------------------

The raw data is electronically submitted by MSs and non‐MSs. The data that must be submitted consist of testing data and case‐based data for bovine animals and small ruminants according to the reporting periods (monthly basis) as described in Chapter B.I of Annex III.

Electronically submitted data are stored in the EU database and can be consulted using business intelligence tools (Business Objects). The electronically submitted data were extracted from the EU database and further processed and validated by the European Food Safety Authority (EFSA) to summarise the information and to elaborate the summary tables presented in the current European summary report (EUSR).

The remaining data (e.g. genotype data, bovine animals tested according the required age classes, surveillance of TSE in animals other than bovine animals, ovine and caprine animals as well as CWD in cervids) were provided by the MSs in their annual reports submitted in accordance with Article 6.4 of, and as specified in Chapter B.I, Annex III to, the TSE Regulation. Genotype data for positive scrapie ovine cases and for national representative sampling were retrieved from annual reports submitted by the MSs. Data from both the cases and the sample of genotyped sheep were provided as described in the TSE Regulation Chapter A, Part II, point 8.1 or point 8.2.

Finally, information on the population of small ruminants in 2016 (as presented in Table [4](#efs25069-tbl-0004){ref-type="table"}) and the number of BSE cases worldwide (as presented in Table [7](#efs25069-tbl-0007){ref-type="table"}) was obtained from the last available report on the monitoring and testing of ruminants for the presence of TSE in the EU by the EC (European Union, [2016](#efs25069-bib-0020){ref-type="ref"}) and OIE (<http://www.oie.int/wahis>), respectively.

The data in this report refer only to the samples collected and confirmed cases reported between 1 January 2016 and 31 December 2016 in the EU and three additional non‐MS European Free Trade Association (EFTA) reporting countries (Iceland, Norway and Switzerland). EFSA validated the 2016 data by checking for inconsistencies between the data in the annual reports and the electronically extracted data, and by comparing the reported data with previous years. Data providers in the reporting countries were consulted during this validation. The data validation was started in April 2017 and finalised on 20 June 2017. The results and tables presented in the current EUSR are based on the data retrieved from the EU database on 1 July 2017. An additional consultation period with MSs was conducted between 27 September 2017 and 13 October 2017. If historical data (Tables [7](#efs25069-tbl-0007){ref-type="table"}, [8](#efs25069-tbl-0008){ref-type="table"} to [9](#efs25069-tbl-0009){ref-type="table"} for BSE, Tables [15](#efs25069-tbl-0015){ref-type="table"}, [16](#efs25069-tbl-0016){ref-type="table"}, [17](#efs25069-tbl-0017){ref-type="table"}--[18](#efs25069-tbl-0018){ref-type="table"} for Scrapie) were corrected by the MSs during consultation, EFSA made these changes directly in the tables or made this clear by means of footnotes. EFSA asked the MS to update these changes in the EU database.

For some tables and figures, historical data (period 2001--2016) were extracted from the EU TSE database. As certain MSs and non‐MSs may calculate their annual statistics using different reporting criteria (e.g. based on the date of final test results rather than the date of sampling), the data summarised in this report may differ slightly from the national figures published by single MSs for 2016. In addition, subsequent submissions of updated/amended data by MSs may have resulted in differences in the figures included in this report when compared with the same data presented in previous EU summary reports.

2.2. Presentation of the data {#efs25069-sec-0015}
-----------------------------

The current report should be considered the EC summary report for 2016 in compliance with Section II, Chapter B, Annex III of the TSE Regulation.

The 28 EU Member States are referred to as MSs or EU28, and non‐Member States as non‐MSs when they belong to EFTA reporting countries. The non‐MSs in this report are Iceland, Norway and Switzerland. The data reported by Switzerland include those of Lichtenstein. The countries are quoted in this report by using the country codes from the Nomenclature of Units for Territorial Statistics (NUTS) or the English name according to Regulation (EC) No 1059/2003[9](#efs25069-note-1011){ref-type="fn"}.

For some tables and figures, the surveillance target groups were combined: FS, ES and AM in bovine animals have been included in the group 'risk animals'. The word 'risk' is used hereinafter to indicate those animals whose probability of being detected with the disease is higher than in another surveillance target group (e.g. HS) but did not experience a higher level of exposure than normal (Doherr et al., [2001](#efs25069-bib-0003){ref-type="ref"}). The same holds for small ruminants from the NSHC target group (Bird, [2003](#efs25069-bib-0002){ref-type="ref"}) when tested from non‐infected flocks.

2.3. Methods {#efs25069-sec-0016}
------------

### 2.3.1. Descriptive methods {#efs25069-sec-0017}

To describe the results of the TSE surveillance programme in the EU in 2016, a number of figures and tables have been produced along with a short narrative text to describe the main findings. The report is split into three sections: bovine animals (cattle), small ruminants (sheep and goats) and species other than bovine, ovine and caprine animals. Both aggregated data and data at the national level are presented. Where it was considered relevant, multi‐year and historical data are shown: surveillance data were available for the period 2001--2016 for bovine animals, for 2002--2016 for small ruminants, and only for the reporting year (2016) for other species.

In the case of bovine animals, summary statistics were obtained based on the total number of tests performed in 2016 by MS and surveillance target group. In addition, historical data relating to the number of tested animals and confirmed cases since 2001 are summarised. Additional epidemiological parameters have been estimated: for example, absolute number of cases or proportions (cases per million tests) by case type (e.g. C‐BSE, H‐BSE, L‐BSE) and/or surveillance target group, and proportions (cases per million tests) by age‐class and by year, among others. These have been used to describe the evolution of the BSE epidemic and to put into context the findings of the reporting year.

A comparison between the average number of cases detected per 1,000,000 tests at the EU level in risk animals and HS target group has been carried out by means of a t‐test performed on data from the last 10 years (period 2007--2016). Moreover, the same data have been used to check if any significant temporal trend was detectable. For this purpose, a Poisson regression model has been fitted for each BSE type (C‐BSE, H‐BSE and L‐BSE) separately, using the number of cases as dependent variable and the year as a continuous independent variable; the number of tests was used as offset. The target group (risk animals vs. HS) was added to the model as covariate to adjust for any potential confounding effect. A p‐value ≤ 0.05 was considered statistically significant for both the statistical analyses.

In order to obtain relevant epidemiological information about the BSE cases detected in 2016, EFSA requested additional information from the individual MSs concerned via a small questionnaire.

For small ruminants, summary statistics are presented in this report, and where possible, stratified according to the relevant variables in the database such as: surveillance target group (SHC, NSHC, SU, EM), flock status (infected, non‐infected, other, unknown), surveillance type (passive surveillance restricted to SU vs active surveillance restricted to SHC and NSHC in non‐infected flocks), country, year (since 2002), case type (CS or AS), index case (yes/no).

Based on the minimum testing requirements for TSE surveillance in small ruminants (Table [4](#efs25069-tbl-0004){ref-type="table"}), a check has been carried out of the compliance of each MS. For assessing compliance, the following criteria have been applied: For testing in the NSHC surveillance target group: if the difference between observed testing and expected testing (minimum requirements) was positive, then the MS is compliant with the testing requirements.For testing in the SHC surveillance target group: if the difference between observed testing and expected testing (minimum requirements) was positive, the MS is compliant; when the difference was negative, a further calculation was performed to check if the MS\'s compliance had been achieved by applying the derogation provided by the TSE Regulation (According to point II.2(c), Chapter A, Annex III of the TSE Regulation) i.e. replacing up to 50% of its minimum SHC sample size by testing dead ovine or caprine animals over the age of 18 months at the ratio of one to one and in addition to the minimum sample size for NSHC.

A MS has been considered to meet the minimum requirements when the above criteria have been met in both target groups.

Also in small ruminants, a comparison between the average number of cases per 10,000 tests detected at the EU level in NSHC and SHC surveillance groups has been carried out for animals tested on non‐infected flocks: here, a t‐test was used on data from the last 10 years (period 2007--2016). Moreover, the same data have been used to check if any significant temporal trend was detectable: a Poisson regression model has been fitted for ovine and caprine animals separately, using the number of cases as dependent variable, the year as a continuous independent variable; the number of tests was used as offset. The target group was added to the model as covariate to adjust for any potential confounding effect. A p‐value ≤ 0.05 was considered statistically significant for both the statistical analyses.

To visualise a potential evolution (period 2002--2016) in the number of CS cases over the number of AS cases in sheep, an annual ratio (CS:AS) was plotted for each MS. A correction was applied for those MSs for which the numerator or denominator was equal to zero. In those cases, the ratio was replaced by a value calculated using the following formula: (CS + 0.5) ⁄ (AS + 0.5). No calculation was carried out for years in which neither CS nor AS cases were detected. Finally, a log scale was used for the Y‐axis to include all surveillance target groups in the same figure. The CS/AS plot can be interpreted by assuming that the occurrence of AS is homogeneously distributed in the EU and is not influenced by breeding programmes or the control measures. After a visual inspection of the national graphs, data from MSs with similar patterns have been combined to build separate graphs showing three main clusters: (1) a CS:AS ratio that is always below one; (2) a decreasing CS/AS ratio over time (crossing the ratio one at some point); and (3) a CS/AS ratio that is always greater than one (more CS than AS cases have been consistently detected).

The mean age of the AS cases has been compared with that of CS cases in sheep and goats by applying a two‐sample t‐test with unequal variances. A p‐value ≤ 0.05 was considered statistically significant.

Finally, the classification originally developed by Great Britain\'s National Scrapie Plan (NSP) was used to summarise and describe the data on genotyping. Moreover, in order to identify the evolution of the effect of breeding against resistance in some MSs, the five NSP groups were recategorised into three groups, namely, resistant (homozygous ARR), semi‐resistant (heterozygous ARR except ARR/VRQ) and susceptible (non‐ARR except ARR/VRQ).

In order to describe and plot the reported data, some assumptions were made for reporting the results in bovine animals and small ruminants (sheep and goats): With regards to bovine animals, to plot the temporal evolution of BSE cases (C‐BSE, L‐BSE and H‐BSE), cases for which the type was reported as 'Unknown' or was missing were considered for reporting purposes as C‐BSE, since most of these were reported before 2005.In small ruminants, the following assumptions were considered:--To plot the reported scrapie cases according to the flock status, it was assumed that flocks with status reported as 'unknown', 'other' or blank were considered for reporting purposes as 'non‐infected flocks'.--To describe the evolution of the total number of scrapie index cases, it was assumed that all index cases ('yes') were confirmed in non‐infected flocks. If an index case was reported as 'no' or 'unknown', it was considered for reporting purposes as 'infected flocks'.--To describe the results of the discriminatory TSE testing, it was assumed that all scrapie cases with 'BSE‐like', 'non BSE‐like' or 'inconclusive' results in the primary or secondary molecular tests have been submitted for discriminatory testing.

3. Assessment {#efs25069-sec-0018}
=============

3.1. BSE surveillance in bovine animals {#efs25069-sec-0019}
---------------------------------------

Circa 115 million bovine animals were tested for BSE between 2001 and 2016. As shown in Figure [3](#efs25069-fig-0003){ref-type="fig"}, the number of bovine samples tested for BSE decreased over the years. There was a 6% reduction in the total number of samples tested in the EU from 1,442,446 in 2015 to 1,352,585 in 2016. The target surveillance group most affected by this reduction was the HS, with a 20% reduction from 491,052 in 2015 to 390,586 in 2016 (mainly due to reductions in Germany, France and Poland), as shown in Table [5](#efs25069-tbl-0005){ref-type="table"}. Compared with 2015, the number of samples tested from risk animals (AM + ES + FS) over 48 months of age showed an increase (+ 28,118), mainly attributable to a few countries (France, Ireland and the United Kingdom). Currently, over 71% of all samples tested in the 31 reporting countries is obtained solely from the FS surveillance target group.

![Total number of bovine animals tested for BSE in the EU over the period 2001--2016 by surveillance target group. (A) surveillance target groups HS and FS; (B) surveillance target groups ES,AM,EM and SU\
The figure does not include: data from Norway, Switzerland and Iceland reporting ca. 270,000 tests between 2003 and 2016; 1,500 animals tested in 2003 and submitted for rapid testing without a clear indication of the target group.SU: Animals clinically suspected of being infected with BSE;FS: fallen stock; ES: emergency slaughtered; AM: animals with clinical signs at *ante‐mortem*;HS: healthy slaughtered; EM: animals culled under BSE eradication measures.](EFS2-15-e05069-g003){#efs25069-fig-0003}

The number of cattle tested for BSE per reporting country for each surveillance target group in 2016 is shown in Table [5](#efs25069-tbl-0005){ref-type="table"}. The number of tested bovine animals per MS and per age category for each of the target surveillance groups is summarised in Appendix [A](#efs25069-sec-1001){ref-type="sec"} (Tables [A.1](#efs25069-tbl-0026){ref-type="table"}--[A.5](#efs25069-tbl-0030){ref-type="table"}).

###### 

Number of bovine animals tested for BSE by reporting country and surveillance target group in 2016 in the EU and other reporting countries

  Country          Surveillance target group   Total                                                                       
  ---------------- --------------------------- ----------- ------------- ------------- ------------- --------- ----------- ---------------
  AT               3,011                       77          13,456        16,544        3,355         15        0           19,914
  BE               810                         2           24,955        25,767        42            27        0           25,836
  BG               1,788                       0           524           2,312         18,546        0         0           20,858
  CY               0                           0           916           916           0             0         0           916
  CZ               909                         0           14,569        15,478        36            2         0           15,516
  DE               9,090                       1           151,297       160,388       536           461       0           161,385
  DK               1,307                       0           19,367        20,674        21            1         0           20,696
  EE               80                          28          3,465         3,573         0             0         0           3,573
  EL               26                          28          1,701         1,755         9,253         6         1,091       12,105
  ES               242                         30          62,231        62,503        302           3         11          62,819
  FI               39                          1           11,190        11,230        4             0         0           11,234
  FR               11,981                      0           202,519       214,500       41,594        5         61          256,160
  HR               402                         0           5,881         6,283         12,327        1         0           18,611
  HU               142                         627         11,098        11,867        1,705         2         0           13,574
  IE               0                           706         58,659        59,365        0             0         0           59,365
  IT               13,357                      623         38,268        52,248        597           0         0           52,845
  LT               53                          22          3,095         3,170         0             0         0           3,170
  LU               0                           0           2,408         2,408         0             2         0           2,410
  LV               74                          212         2,695         2,981         0             3         0           2,984
  MT               70                          0           104           174           0             1         0           175
  NL               5,411                       0           49,456        54,867        21            0         0           54,888
  PL               4,388                       456         32,498        37,342        131,825       20        0           169,187
  PT               1,589                       1,555       15,931        19,075        603           1         0           19,679
  RO               1,792                       174         3,113         5,079         169,722       70        0           174,871
  SE               190                         20          8,750         8,960         1             2         0           8,963
  SI               406                         84          5,657         6,147         79            13        0           6,239
  SK               51                          5           7,618         7,674         0             0         0           7,674
  UK               3,391                       918         142,590       146,899       17            1         21          146,938
  **Total EU**     **60,599**                  **5,569**   **894,011**   **960,179**   **390,586**   **636**   **1,184**   **1,352,585**
  CH               4,719                       0           6,874         11,593        0             35        0           11,628
  IS               1                           0           12            13            127           0         0           140
  NO               5,099                       73          1,754         6,926         1             0         0           6,927
  **Total EFTA**   9,819                       73          8,640         18,532        128           35        0           18,695
  **Total**        **70,418**                  **5,642**   **902,651**   **978,711**   **390,714**   **671**   **1,184**   **1,371,280**

SU: Animals clinically suspected of being infected with BSE; FS: fallen stock; ES: emergency slaughtered; AM: animals with clinical signs at *ante‐mortem*; HS: healthy slaughtered; EM: animals culled under BSE eradication measures.

John Wiley & Sons, Ltd

In 2016, five BSE cases were reported by two different MSs (France and Spain). All cases were detected in the FS target surveillance group.

One of the four French cases was confirmed C‐BSE and had been born in 2011: the animal was 59 months old and this is the first time since 2008 that a case has been detected in the age class \< 60 months. It has been classified as a BARB case, i.e. born after 1 January 2001 when the 2001 EU‐wide reinforcement of the European Union feed ban was implemented. Recently, an EFSA Opinion (EFSA BIOHAZ Panel, [2017a](#efs25069-bib-0006){ref-type="ref"}) has been dedicated to the investigation of the origin of the 60 BARB cases detected in the EU since 2001.

The remaining four cases were all of H‐BSE type (three from France and one from Spain) and were detected in old animals (all were over 133 months of age).

Table [6](#efs25069-tbl-0006){ref-type="table"} reports the main characteristics and epidemiological information relating to the positive cases, e.g. the presence of clinical symptoms, herd size, herd type, animal and feed type. This additional information was obtained from a small questionnaire sent in July 2017 to the TSE reporting officers of France and Spain.

###### 

Clinical and epidemiological description of the five BSE cases detected in 2016 by Spain and France

  Country                                                                        ES -- atypical                              FR -- atypical1                                                                                                            FR -- atypical2                FR ‐ atypical3                                                                                     FR -- classical
  ------------------------------------------------------------------------------ ------------------------------------------- -------------------------------------------------------------------------------------------------------------------------- ------------------------------ -------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------
  **Surveillance target group**                                                  Fallen stock                                Fallen stock                                                                                                               Fallen stock                   Fallen stock                                                                                       Fallen stock
  **Case type**                                                                  H‐BSE                                       H‐BSE                                                                                                                      H‐BSE                          H‐BSE                                                                                              C‐BSE
  **Month and year of birth**                                                    March 2000                                  March 2001                                                                                                                 May 2002                       December 2004                                                                                      April 2011
  **Age at detection (in months)**                                               193                                         186                                                                                                                        165                            133                                                                                                59
  **BARB status**                                                                No                                          No                                                                                                                         No                             No                                                                                                 Yes
  **Clinical symptoms**                                                          Sialism                                     This cow was euthanised after an accident (slip on wet grass). It was found lying on its back and was unable to stand up   None                           The pregnant cow had paresis. It was euthanised after a caesarean section resulted in paraplegia   Euthanasia following a fall
  **Cattle type**                                                                Beef                                        Beef                                                                                                                       Beef                           Beef                                                                                               Beef
  **Breed**                                                                      Morucha                                     Charolaise                                                                                                                 Limousine                      Charolaise                                                                                         Salers
  **Was the case confirmed at herd/holding where the animal was born?**          Yes                                         Yes                                                                                                                        No                             Yes                                                                                                Yes
  **Location (NUTS3) of natal herd or herd where case found**                    Castilla y León Region/Salamanca province   Côte d\'Or                                                                                                                 Corrèze                        Allier                                                                                             Ardennes
  **Herd size**                                                                  127                                         50                                                                                                                         80                             270                                                                                                394
  **Herd type**                                                                  Beef production                             Beef                                                                                                                       Beef                           Beef                                                                                               Beef/mixed (also sheep)
  **Feeding system during first year of life**                                   Suckle, concentrate, pasture                NA                                                                                                                         Unknown, herd closed in 2007   Hay, mash, mineral supplement, reconstituted milk for orphans and twins                            Extensive livestock; calf under the mother, pasture, hay; few concentrate and mixed.
  **Feed cohorts? Tested? If Yes: Results (number tested; number positives)**    No                                          No                                                                                                                         Yes (1;0)                      Yes (8;0)                                                                                          Yes (1;0)
  **Birth cohorts? Tested? If Yes: Results (number tested; number positives)**   Yes (10;0)                                  Yes (1;0)                                                                                                                  Yes (1;0)                      Yes; (8;0)                                                                                         Yes (54;0)
  **Offspring? Tested? If Yes: Results (number tested; number Positives)**       Yes (1;0)                                   Yes (1;0)                                                                                                                  Not tested                     Yes (NA)                                                                                           Yes (1;0)
  **Sire? Tested? (Yes/No). If Yes: Results (positive? negative?)**              NA^(a)^                                     Yes, negative                                                                                                              Not tested                     Yes, negative                                                                                      Not tested
  **Dam? Tested (Yes/No). If Yes: Results (positive? negative?)**                Yes, negative                               Yes, negative                                                                                                              NA^(a)^                        Yes, negative                                                                                      Yes, negative

NA: Not available; BARB: Born after the reinforced feed ban.

John Wiley & Sons, Ltd

The total number of BSE cases worldwide by year and country since the 1990 is displayed in Table [7](#efs25069-tbl-0007){ref-type="table"}. The occurrence of C‐BSE since 2001 (highlighting the occurrence of BARB cases) and of the atypical cases are shown in Tables [8](#efs25069-tbl-0008){ref-type="table"} and [9](#efs25069-tbl-0009){ref-type="table"}, respectively. In 2016, no BSE cases were detected outside the EU. The cumulative geographical distribution of C‐BSE, H‐BSE and L‐BSE in the EU is shown in Appendix [C](#efs25069-sec-1003){ref-type="sec"}.

Comparing C‐BSE cases with the two previous years (three cases in 2014 and five in 2015), there was no apparent difference in the proportion of cases per million tests. Figure [5](#efs25069-fig-0005){ref-type="fig"} shows the evolution of the proportion of BSE cases (per 1,000,000 tests) by case type. Over the last 10 years, the average number of C‐BSE cases per 1,000,000 in the risk animals is higher (p value \< 0.03) than in HS animals (18.7 vs 1.6). The same is true for H‐BSE (2.8 vs 0.2, p value \< 0.0001) and L‐BSE (1.9 vs 0.6, p = 0.04).

As described in the previous 2015 TSE EU summary report,[6](#efs25069-note-1008){ref-type="fn"} C‐BSE in the EU has trended downwards over time, with only 5 cases reported in the EU28 in the last 3 years (Figure [4](#efs25069-fig-0004){ref-type="fig"}). For the first time since BSE cases have been reported, no C‐BSE or atypical BSE cases were reported by the United Kingdom in 2016.

Since 2007, the EU trend in the proportion of C‐BSE cases (per 1,000,000 tests), adjusted by target group, has been decreasing from 68.4 in 2007 to 1 in 2016 (Beta = −0.4, p value \< 0.0001).

![Number of BSE cases by type over the period 2001--2016 in the EU Left y‐axis: C‐BSE  + U + B. Right y‐axis: L‐ to H‐BSE and L‐BSE.One case from Poland in 2012 that was reported as 'atypical' is not included in the figure.Cases reported as unknown (U) or blank/missing (B) were combined with C‐BSE cases.The figure does not include data from non‐MSs (Norway (1 case), Switzerland (101 cases)) over the same period. Number of cases of C‐BSE + U + B by year of detection: 2010:37; 2011:21; 2012:11; 2013:2; 2014:3; 2015:2; 2016:1.](EFS2-15-e05069-g004){#efs25069-fig-0004}

###### 

Total number of reported BSE cases (Classical‐BSE (including cases reported as 'Unknown') + Atypical H‐BSE + Atypical L‐BSE) in the EU and worldwide by year (period 1991--2016) and country

  Country            Year                                        Total                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  ------------------ ------------------------------------------- ------------------------------------------- ------------------------------------------- ------------------------------------------ ------------------------------------------- ------------------------------------------- ----------- ------------------------------------------ ----------- ------------------------------------------- -------------------------------------------- ------------------------------------------- ------------------------------------------------ ------------------------------------------ ------------------------------------------------ ------------- ----------------------------------------------- ------------ ------------ ------------ ----------- ----------- ------------------------------------------------ -------- ----------- -------- -------- -------------
  **AT**             3                                                                                                                                                                                                                                                                                                                                                                                                                                  1                                                                                                                                                                                        2             2                                               1 (1L)                                 2 (1H/1L)                                                                                                       **11**
  **BE**                                                                                                                                                                                                                                                                                                1                                          6           3                                           9                                            46                                          38                                               15                                         11                                               3             1                                                                                                                                                                                                      **133**
  **CZ**                                                                                                                                                                                                                                                                                                                                                                                                                                                2                                           2                                                4                                          7                                                8             3                                               2 (1H)                    2                                                                                                                            **30**
  **DE**                                                                                                     1[a](#efs25069-note-0022){ref-type="fn"}    0                                          3[a](#efs25069-note-0022){ref-type="fn"}                                                            2[a](#efs25069-note-0022){ref-type="fn"}                                                           7                                            125                                         106 (1L)                                         54 (1L)                                    65 (1H)                                          32            16                                              4            2            2                                                                                              2 (1H/1L)                     **421**
  **DK**                                                                                                     1[a](#efs25069-note-0022){ref-type="fn"}                                                                                                                                                                                                                                                      1                                            6                                           3                                                2                                          1 (1L)                                           1                                                                                       1                                                                                                                            **16**
  **EL**                                                                                                                                                                                                                                                                                                                                                                                                                                                1                                                                                                                                                                                                                                                                                                                                                                                                             **1**
  **ES**                                                                                                                                                                                                                                                                                                                                                                                                   2                                            83                                          134                                              173 (1H)                                   138                                              103           76 (1H)                                         33 (1L)      24 (1H/1L)   18 (2H/2L)   13          7 (1H)      6 (1H/2L)                                                 2 (1L)      1 (1L)   1 (1H)   **814**
  **FI**                                                                                                                                                                                                                                                                                                                                                                                                                                                1                                                                                                                                                                                                                                                                                                                                                                                                             **1**
  **FR**                                                         5                                                                                       1                                          4                                           3                                           12          6                                          18          31[a](#efs25069-note-0022){ref-type="fn"}   162                                          277 (1H)                                    240 (2H/1L)                                      111 (3H/1L)                                51 (1L)                                          32 (1L)       8 (2L)                                          7 (1H/1L)    8 (2H/3L)    10 (2H/2L)   5 (2H/1L)   3           1 (1L)                                           2 (2H)   3 (1H/2L)            4 (3H)   **1,004**
  **IE**             29[a](#efs25069-note-0022){ref-type="fn"}   17[a](#efs25069-note-0022){ref-type="fn"}   18[a](#efs25069-note-0022){ref-type="fn"}   16                                         19[a](#efs25069-note-0022){ref-type="fn"}   16[a](#efs25069-note-0022){ref-type="fn"}   74          80                                         83          95                                          149                                          246                                         333 (1H)                                         182                                        126                                              69            41                                              25           23           9            2 (1H)      3 (1H)      3                                                1 (1H)               1                 **1,660**
  **IT**                                                                                                                                                                                            2[a](#efs25069-note-0022){ref-type="fn"}                                                                                                                                                                                                            50[a](#efs25069-note-0022){ref-type="fn"}   36 (1L)[a](#efs25069-note-0022){ref-type="fn"}   31 (1L)                                    7                                                8             7                                               2 (1L)       1            2 (1L)                   1 (1L)                                                                                              **147**
  **LU**                                                                                                                                                                                                                                                                                                1                                                                                                                                                                                           1                                                                                                                                            1                                                                                                                                                                                                                    **3**
  **NL**                                                                                                                                                                                                                                                                                                2                                          2           2                                           2                                            19 (1H)                                     24 (1L)                                          19 (1L)                                    6                                                3             2                                               2            1                         3 (1L)                                                                                                          **87**
  **PL**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            4 (1L)                                           5                                          11 (2L)                                          20 (2L)       10 (1H/1L)                                      9 (2L)       5            4 (1H)       2           1 (1L)      3 (2L, 1A)                                       1 (1L)                                 **75**
  **PT**             1[a](#efs25069-note-0022){ref-type="fn"}    1[a](#efs25069-note-0022){ref-type="fn"}    1[a](#efs25069-note-0022){ref-type="fn"}    3[a](#efs25069-note-0022){ref-type="fn"}   12                                          15                                          31          30                                         127         159                                         149[a](#efs25069-note-0022){ref-type="fn"}   110                                         86                                               133                                        92 (1H)[a](#efs25069-note-0022){ref-type="fn"}   53 (2H)       32                                              13 (1H)      19 (2H)      6            5           5 (1H)      2                                                         1                             **1,086**
  **RO**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                2 (2L)                        **2**
  **SE**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       1 (1H)[b](#efs25069-note-0023){ref-type="fn"}                                                                                                                                                          **1**
  **SI**                                                                                                                                                                                                                                                                                                                                                                                                                                                1                                           1                                                1                                          2[a](#efs25069-note-0022){ref-type="fn"}         1             1                                               1                                                                                                                                    1 (1H)            **9**
  **SK**                                                                                                                                                                                                                                                                                                                                                                                                                                                5                                           6                                                2                                          7                                                3                                                             2            1                         1                                                                                                               **27**
  **UK**             24,595                                      25,359                                      37,280                                      35,090                                     24,438                                      14,562                                      8,149       4,393                                      3,235       2,301                                       1,443                                        1,203                                       1,123                                            610                                        330                                              208 (1H/1L)   129 (1L)                                        65 (2H/2L)   42 (2L)      11 (1H)      11 (1L)     8 (1H/1L)   3 (1L)                                           3 (1H)   1           2 (1H)            **184,594**
  **Total EU‐28**    **24,628**                                  **25,382**                                  **37,301**                                  **35,110**                                 **24,478**                                  **14,596**                                  **8,266**   **4,515**                                  **3,471**   **2,591**                                   **1,924**                                    **2,176**                                   **2,137**                                        **1,342**                                  **854**                                          **547**       **329**                                         **166**      **126**      **65**       **44**      **28**      **18**                                           **7**    **11**      **5**    **5**    **190,122**
  **BRA**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1                                                         1 (1H)                        **2**
  **CAN**                                                                                                                                                1[a](#efs25069-note-0022){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                    1                                          1                                                1             5                                               3            4            1            1           1                                                                                 1                 **20**
  **ISR**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1                                                                                                                                                                                                                                                                                                                                                                 **1**
  **JPN**                                                                                                                                                                                                                                                                                                                                                                                                                                               3                                           2                                                4                                          5                                                7             10                                              3            1            1                                                                                                                            **36**
  **LI**                                                                                                                                                                                                                                                                                                                                           2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  **2**
  **NO**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1 (1H)            **1**
  **CH**             2                                           8                                           15                                          29                                         64                                          68                                          45          38                                         14          50                                          33                                           42                                          24                                               21                                         3                                                3             5                                               0            0            0            0           2 (2A)      1 (1H) [a](#efs25069-note-0022){ref-type="fn"}                                          **467**
  **USA**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1[a](#efs25069-note-0022){ref-type="fn"}                                                    1             1                                                                                                              1                                                                                       **4**
  **Total Non EU**   **2**                                       **8**                                       **15**                                      **30**                                     **64**                                      **68**                                      **45**      **38**                                     **16**      **50**                                      **33**                                       **45**                                      **27**                                           **27**                                     **9**                                            **12**        **21**                                          **6**        **5**        **2**        **1**       **3**       **3**                                            **0**    **1**       **2**    **0**    **533**
  **Total**          **24,630**                                  **25,390**                                  **37,316**                                  **35,140**                                 **24,542**                                  **14,664**                                  **8,311**   **4,553**                                  **3,487**   **2,641**                                   **1,957**                                    **2,221**                                   **2,164**                                        **1,369**                                  **863**                                          **559**       **350**                                         **172**      **131**      **67**       **45**      **31**      **21**                                           **7**    **12**      **7**    **5**    **190,655**

BRA: Brazil; CAN: Canada; ISR: Israel; JPN: Japan; USA: The United States of America.

Each cell reports the total number of BSE cases (C‐BSE (including cases reported as 'Unknown' ) + H‐BSE + L‐BSE). EU countries without BSE cases (Bulgaria, Cyprus, Estonia, Croatia, Hungary, Lithuania, Latvia and Malta) are not reported.

Source: data regarding non‐EU cases and cases in EU Member States for the period 1987--2002 were made available by the European Commission (European Union, [2016](#efs25069-bib-0020){ref-type="ref"}). Data were retrieved from the EU TSE Database and the OIE website (<http://www.oie.int/wahis>).

Included imported cases: CAN one case in 1993; Denmark one case in 1992; France one case in 1999; Germany one case in 1992, three cases in 1994, two cases in 1997; Ireland 5 cases in 1989, one case in 1990, 2 cases in 1991 and 1992, one case in 1994 and one case in 1995; Italy two cases in 1994 and one case in 2001 and 2002; Portugal one case in 1990, 1991, 1992, 2000 and 2004 and three cases in 1993; Slovenia one case in 2004; Switzerland one case in 2012; USA one case in 2003.

Gavier‐Widen et al. ([2008](#efs25069-bib-0008){ref-type="ref"}).
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###### 

Number of reported Classical BSE cases in the EU and CH by year (period 2001--2016) and country

  Country          Year                                         Total                                                                                                                                                     
  ---------------- -------------------------------------------- ----------- ----------- ----------- --------- --------- --------- --------- --------- -------- -------- -------- -------- ------- ------- ------- ------- -------------
  AT                                                            1                                             2         2                                                                                                 5
  BE               19                                           46          38          15          11        3         1                                                                                                 133
  CZ                                                            2           2           4           7         8         3         1                   2                                                                   29
  DE               13[b](#efs25069-note-0240){ref-type="fn"}    125         105         53          64        32        16        4         2         2                                                                   416
  DK               2[a](#efs25069-note-0024){ref-type="fn"}     6           3           2                     1                                       1                                                                   15
  EL                                                            1                                                                                                                                                         1
  ES               2                                            83          134         172         138       103       75        32        22        14       13       6        3                1                       798
  FI                                                            1                                                                                                                                                         1
  FR               242[b](#efs25069-note-0240){ref-type="fn"}   276         237         107         50        31        6         5         3         6        2        3                                         1       969
  IE               596[b](#efs25069-note-0240){ref-type="fn"}   246         332         182         126       69        41        25        23        9        1        2        3                        1               1,656
  IT               2[b](#efs25069-note-0240){ref-type="fn"}     50          35          30          7         8         7         1         1         1                                                                   142
  LU               1                                                        1                                 1                                                                                                           3
  NL               8                                            18          23          18          6         3         2         2         1                  2                                                          83
  PL                                                                        3           5           9         18        8         7         5         3        2                                                          60
  PT               529[b](#efs25069-note-0240){ref-type="fn"}   110         86          133         91        51        32        12        17        6        5        4        2                1                       1,079
  SI                                                            1           1           1           2         1         1         1                                                                                       8
  SK                                                            5           6           2           7         3                   2         1                  1                                                          27
  UK               180,845                                      1,203       1,123       610         330       206       128       61        40        10       10       6        2        2       1       1               184,578
  **Total EU28**   **182,259**                                  **2,174**   **2,129**   **1,334**   **848**   **540**   **322**   **153**   **115**   **54**   **36**   **21**   **10**   **2**   **3**   **2**   **1**   **190,003**
  CH               366                                          42          24          21          3         3         5                                                                                                 464
  Total EFTA       366                                          42          24          21          3         3         5                                                                                                 464
  **Total**        **182,625**                                  **2,216**   **2,153**   **1,355**   **851**   **543**   **327**   **153**   **115**   **54**   **36**   **21**   **10**   **2**   **3**   **2**   **1**   **190,467**

Each cell reports the total number of C‐BSE cases. EU countries without C‐BSE cases (Bulgaria, Cyprus, Estonia, Croatia, Hungary, Lithuania, Latvia, Malta, Romania and Sweden) are not reported. Grey shaded cells indicate the year and Member State where at least one BARB case was detected (EFSA BIOHAZ Panel, [2017a](#efs25069-bib-0006){ref-type="ref"}).

Source: data were retrieved from the EU TSE Database except for CH.

One of these cases was imported from the United Kingdom.

Include imported cases.

John Wiley & Sons, Ltd

###### 

Number of reported BSE Atypical cases in EU and EFTA countries by year (period 2001--2016), type and country

  Country code      Year    Total                                                                                                                                                                                                                                                                                               
  ----------------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------------------------------------------ ------- ------- ------- ------- ------- ------- ------- ------- -------- --------
  AT                                                                                                                        1                                       1       1                                                                                                                                          1        2
  CZ                                                                                                                1                                                                                                                                                                                                  1        
  DE                                        1               1       1                                                                                                                                                                                                  1       1                                       2        3
  DK                                                                        1                                                                                                                                                                                                                                                   1
  ES                                                1                                               1                       1       1       1       2       2                       1               1       2                                                                  1               1       1               8        8
  FR                1               2       1       3       1               1               1               2       1       1       2       3       2       2       2       1                               1                                          2               1       2                       3               19       16
  IE                                1                                                                                                                               1               1                                                                  1                                                               4        
  IT                                        1               1                                                               1                               1                               1                                                                                                                                   5
  NL                1                       1               1                                                                                                               1                                                                                                                                          1        3
  PL                                        1                               2               2       1       1               2                       1                                       1               2[a](#efs25069-note-0028){ref-type="fn"}           1                                                       2        12
  PT                                                                1               2                               1               2                                               1                                                                                                                                  7        
  RO                                                                                                                                                                                                                                                                           2                                                2
  SE                                                                                                1                                                                                                                                                                                                                  1        
  SI                                                                                                                                                                                                                                                                                   1                               1        
  UK                                                                                1       1               1       2       2               2       1                       1       1       1               1                                          1                               1                               7        9
  **Total EU‐28**   **2**   **0**   **3**   **5**   **4**   **4**   **2**   **4**   **3**   **4**   **3**   **4**   **5**   **8**   **5**   **6**   **6**   **5**   **4**   **4**   **4**   **3**   **1**   **6**                                      **4**   **1**   **2**   **6**   **2**   **1**   **4**   **0**   **54**   **61**
  NO                                                                                                                                                                                                                                                                                   1                               1        
  CH                                                                                                                                                                                                1                                                                                                                  1        
  **Total EFTA**                                                                                                                                                                                    **1**                                                                              **1**                           **2**    
  **Total**         **2**   **0**   **3**   **5**   **4**   **4**   **2**   **4**   **3**   **4**   **3**   **4**   **5**   **8**   **5**   **6**   **6**   **5**   **4**   **4**   **4**   **3**   **2**   **6**                                      **4**   **1**   **2**   **6**   **3**   **1**   **4**   **0**   **56**   **61**

Each cell reports the total number of H‐BSE and L‐BSE cases. EU countries without atypical cases (Belgium, Greece, Finland, Luxembourg, Slovakia, Iceland) are not included in the table.

Source: data were retrieved from the EU TSE Database and from the OIE for CH.

In 2012, PL reported an atypical BSE case without specifying the type.
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![Cases per million tested bovine animals by surveillance target group and by case type over the period 2001--2016 in the EU\
A: C(Classical)--BSE + U(Unknown) + B(Blank).](EFS2-15-e05069-g005){#efs25069-fig-0005}

Because of the introduction of mandatory discriminatory testing in 2003 and the retrospective discriminatory testing of BSE cases, 97% of all cases were subjected to confirmatory testing between 2003 and 2016. In total, 621 BSE cases (18%) remain with unknown type status (Table [10](#efs25069-tbl-0010){ref-type="table"}).

Based on the results from discriminatory testing and reporting, a total of 106 atypical BSE cases were reported by the 31 reporting countries during the period 2003--2016 (3% of all cases subject to discriminatory testing): 50 H‐type and 56 L‐Type (excluding one atypical case from Poland in 2012 that could not be defined as H‐ or L‐type).

Focusing on the last 10 years (period 2007--2016), unlike C‐BSE, no apparent trend is detectable for the two atypical BSE forms (H‐BSE: Beta = −0.0003, p value = 0.99, L‐BSE: Beta = −0.04, p value = 0.54; Figure [4](#efs25069-fig-0004){ref-type="fig"}).

###### 

Number and proportion of BSE cases subject to discriminatory testing, by case type for the period 2003--2016

  Country          Total BSE cases   Cases not submitted for discriminatory testing   Cases submitted for discriminatory testing by type                                                                    
  ---------------- ----------------- ------------------------------------------------ ---------------------------------------------------- -------- -------- ----------- ------------ --------- ----------- ------------
  **AT**           7                 0                                                0                                                    1        2        4           100.0%       0         7           100.0%
  **BE**           30                0                                                0                                                    0        0        19          63.3%        11        30          100.0%
  **CZ**           26                0                                                0                                                    1        0        21          84.6%        4         26          100.0%
  **DE**           177               1                                                0                                                    2        2        167         96.6%        5         176         99.4%
  **DK**           5                 0                                                0                                                    0        1        2           60.0%        2         5           100.0%
  **ES**           595               0                                                0                                                    8        8        533         92.3%        46        595         100.0%
  **FR**           245               0                                                0                                                    16       15       201         94.7%        13        245         100.0%
  **IE**           486               0                                                0                                                    4        0        144         30.5%        338       486         100.0%
  **IT**           59                0                                                0                                                    0        4        55          100.0%       0         59          100.0%
  **LU**           1                 0                                                0                                                    0        0        1           100.0%       0         1           100.0%
  **NL**           36                1                                                0                                                    0        2        33          97.2%        0         35          97.2%
  **PL**           71                0                                                1                                                    2        11       57          98.6%        0         71          100.0%
  **PT**           361               97[a](#efs25069-note-0128){ref-type="fn"}        0                                                    7        0        249         70.9%        8         264         73.1%
  **RO**           2                 0                                                0                                                    0        2        0           100.0%       0         2           100.0%
  **SE**           1                 0                                                0                                                    1        0        0           100.0%       0         1           100.0%
  **SI**           7                 0                                                0                                                    1        0        6           100.0%       0         7           100.0%
  **SK**           16                0                                                0                                                    0        0        15          93.8%        1         16          100.0%
  **UK**           1,423             0                                                0                                                    7        9        1,214       86.4%        193       1,423       100.0%
  **Total EU**     **3,548**         **106**                                          **1**                                                **50**   **56**   **2,767**   **81.0%**    **621**   **3,442**   **97.0%**
  **NO**           1                 0                                                0                                                    1        0        0           100.0%       0         1           100.0%
  **Total EFTA**   **1**             **0**                                            **0**                                                **1**    **0**    **0**       **100.0%**   **0**     **1**       **100.0%**
  **Total**        **3,549**         **106**                                          **1**                                                **51**   **56**   **2,767**   **81.0%**    **621**   **3,443**   **97.0**%

The discriminatory testing in PT is still ongoing and database needs to be updated.

The table includes only cases for the period 2003--2016 and only for Member States that reported cases. Categories for case type: L‐BSE, H‐BSE, C‐BSE, Unknown and Blank (missing data).

John Wiley & Sons, Ltd

3.2. TSE surveillance in small ruminants {#efs25069-sec-0020}
----------------------------------------

Since 2002, ca 8.8 million small ruminants have been tested for TSE in the EU. After a peak of testing in 2006 -- due to changes in the TSE Regulation -- the overall number of tested sheep and goats has decreased continuously over time (Figures [6](#efs25069-fig-0006){ref-type="fig"} and [7](#efs25069-fig-0007){ref-type="fig"}). In 2016, a total of 286,351 sheep and 110,832 goats were tested in the EU, respectively, 5% and 11% less than in 2015, and, for both species, mainly restricted to NSHC from non‐TSE‐infected flocks in FR.

The numbers of sheep and goats tested for TSE by reporting country, surveillance target group and flock status in 2016 are summarised in Tables [11](#efs25069-tbl-0011){ref-type="table"} and [12](#efs25069-tbl-0012){ref-type="table"}, respectively. Because of the differences in the size of the small ruminant population, national surveillance efforts differ across reporting countries. Taking into account the number of samples tested in the SHC and NSHC target groups, and those required according to the TSE regulation (Table [4](#efs25069-tbl-0004){ref-type="table"}), 23 MSs fulfilled the requirements for sheep testing and 17 fulfilled the requirements for goat testing.

The ratio of tested sheep in TSE‐infected vs non‐TSE‐infected flocks in the EU was 1:17.8 in 2016, which is slightly lower than in 2015 when the ratio was 1:18.5. The high ratio reveals that, in general, the number of sheep flocks under restrictions is very low. Only 15,230 sheep (5%) were tested from TSE‐infected flocks, and most of those were derived from the culling (EM) of animals in flocks from the three MSs most affected by CS: EL, ES and IT. In goats, the pattern is similar, with ratios of tested goats in TSE‐infected to non‐TSE‐infected flocks of 1:30.4 and 1:23.5 in 2015 and 2016, respectively. The main contributors to goats tested from TSE infected herds were RO, ES and IT even though the main contributor to the CS caseload in the EU is still CY.

Among non‐infected flocks in both species, there is a decreasing trend in the number of sheep and goats notified as clinical suspects and tested as TSE suspects (SU target surveillance group). This may highlight either the decrease in the number of incident clinical cases or a decreasing awareness of scrapie among sheep and goat owners.

![Number of sheep in the EU tested for TSE by surveillance target group (NSHC and SHC in A and B; EM and SU in C and D) and flock status in the period 2006--2016\
Data from Norway, Switzerland and Iceland are not included.A and C: Non‐infected flocks, including 'Other' or 'Unknown'; B and D: TSE‐infected flocks.EM: animals culled under TSE eradication measures; NSHC: Animals not slaughtered for human consumption; SHC: animals slaughtered for human consumption; SU: animals clinically suspected of being infected by a TSE.](EFS2-15-e05069-g006){#efs25069-fig-0006}

![Number of goats in the EU tested for TSE by surveillance target group (NSHC and SHC in A and B; EM and SU in C and D) and flock status in the period 2006--2016\
Data from Norway, Switzerland and Iceland are not included.A and C: Non‐infected flocks, including 'Other' or 'Unknown'. B and D: TSE‐infected flocks.EM: animals culled under TSE eradication measures; NSHC: Animals not slaughtered for human consumption; SHC: animals slaughtered for human consumption; SU: animals clinically suspected of being infected by a TSE.](EFS2-15-e05069-g007){#efs25069-fig-0007}

###### 

Number of sheep tested for TSE by reporting country, surveillance target group and flock status in 2016 in the EU and other reporting countries

  Flock status      Infected flocks   Other flocks[a](#efs25069-note-0032){ref-type="fn"}   Unknown[a](#efs25069-note-0032){ref-type="fn"}   Subtotal non‐infected flocks   Total                                                                                                                                            
  ----------------- ----------------- ----------------------------------------------------- ------------------------------------------------ ------------------------------ ------------ --------- ------------- ------------ -------- ------------- --------- ------------ ------------ -------- ------------ ------------- -------------
  **AT**            0                 13                                                    9                                                0                              22           0         2,532         136          2        2,670         0         0            0            0        0            2,670         2,692
  **BE**            0                 0                                                     0                                                0                              0            0         1,591         0            0        1,591         0         0            0            0        0            1,591         1,591
  **BG**            0                 0                                                     0                                                0                              0            0         457           10,737       0        11,194        0         0            0            0        0            11,194        11,194
  **CY**            0                 0                                                     0                                                0                              0            0         4,567         2,144        0        6,711         0         0            0            0        0            6,711         6,711
  **CZ**            0                 0                                                     0                                                0                              0            0         2,846         28           0        2,874         0         0            0            0        0            2,874         2,874
  **DE**            0                 0                                                     0                                                0                              0            0         0             0            0        0             70        12,322       7,026        36       19,454       19,454        19,454
  **DK**            0                 0                                                     0                                                0                              0            0         680           0            0        680           0         0            0            0        0            680           680
  **EE**            0                 0                                                     0                                                0                              0            0         0             0            0        0             0         300          0            0        300          300           300
  **EL**            1,530             0                                                     0                                                0                              1,530        0         0             0            0        0             0         2,887        3,065        24       5,976        5,976         7,506
  **ES**            5,585             0                                                     0                                                0                              5,585        0         12,681        9,678        1        22,360        0         0            0            0        0            22,360        27,945
  **FI**            0                 0                                                     11                                               0                              11           0         1,381         0            1        1,382         0         0            0            0        0            1,382         1,393
  **FR**            168               9                                                     98                                               0                              275          0         19,622        5,713        1        25,336        0         0            0            0        0            25,336        25,611
  **HR**            0                 0                                                     2                                                0                              2            0         1,755         0            1        1,756         0         0            0            0        0            1,756         1,758
  **HU**            0                 1,171                                                 200                                              0                              1,371        0         6,380         6,234        0        12,614        0         0            0            0        0            12,614        13,985
  **IE**            55                83                                                    232                                              0                              370          0         201           0            0        201           0         10,331       10,530       0        20,861       21,062        21,432
  **IT**            3,150             326                                                   402                                              3                              3,881        2         11,523        10,375       3        21,903        0         0            0            0        0            21,903        25,784
  **LT**            0                 0                                                     0                                                0                              0            0         1,068         163          0        1,231         0         0            0            0        0            1,231         1,231
  **LU**            0                 0                                                     0                                                0                              0            0         101           0            0        101           0         0            0            0        0            101           101
  **LV**            0                 0                                                     0                                                0                              0            0         115           0            0        115           0         0            0            0        0            115           115
  **MT**            0                 0                                                     0                                                0                              0            0         125           67           0        192           0         5            0            0        5            197           197
  **NL**            0                 0                                                     0                                                0                              0            0         0             0            0        0             0         1,520        0            0        1,520        1,520         1,520
  **PL**            0                 0                                                     0                                                0                              0            0         8,638         7,385        0        16,023        0         0            0            0        0            16,023        16,023
  **PT**            0                 0                                                     0                                                0                              0            0         0             0            0        0             214       14,918       6,392        0        21,524       21,524        21,524
  **RO**            0                 86                                                    234                                              40                             360          0         9,275         20,190       43       29,508        0         1,047        1,148        7        2,202        31,710        32,070
  **SE**            0                 0                                                     3                                                0                              3            0         6,368         0            0        6,368         0         0            0            0        0            6,368         6,371
  **SI**            0                 6                                                     0                                                0                              6            0         2,186         202          14       2,402         0         0            0            0        0            2,402         2,408
  **SK**            0                 969                                                   176                                              0                              1,145        0         10,420        0            0        10,420        0         0            0            0        0            10,420        11,565
  **UK**            6                 635                                                   28                                               0                              669          0         14,729        6,916        2        21,647        0         0            0            0        0            21,647        22,316
  **Total EU**      **10,494**        **3,298**                                             **1,395**                                        **43**                         **15,230**   **2**     **119,241**   **79,968**   **68**   **199,279**   **284**   **43,330**   **28,161**   **67**   **71,842**   **271,121**   **286,351**
  **CH**            0                 0                                                     0                                                0                              0            0         0             0            1        1             0         0            0            0        0            1             1
  **IS**            357               0                                                     0                                                0                              357          0         0             2            0        2             0         17           2,359        6        2,382        2,384         2,741
  **NO**            0                 0                                                     0                                                0                              0            168       6,324         9,859        29       16,380        0         0            0            0        0            16,380        16,380
  **Total EFTA**    **357**           **0**                                                 **0**                                            **0**                          **357**      **168**   **6,324**     **9,861**    **30**   **16,383**    **0**     **17**       **2,359**    **6**    **2,382**    **18,765**    **19,122**
  **Total sheep**   **10,851**        **3,298**                                             **1,395**                                        **43**                         **15,587**   **170**   **125,565**   **89,829**   **98**   **215,662**   **284**   **43,347**   **30,520**   **73**   **74,224**   **289,886**   **305,473**

EM: animals culled under TSE eradication measures; NSHC: Animals not slaughtered for human consumption; SHC: animals slaughtered for human consumption; SU: animals clinically suspected of being infected by a TSE.

The 'Other' and 'Unknown' are assumed to be non‐infected flocks.

John Wiley & Sons, Ltd

###### 

Number of goats tested for TSE by reporting country, surveillance target group and herd status in 2016 in the EU and other reporting countries

  Herd status      Infected herds   Other herds[a](#efs25069-note-0034){ref-type="fn"}   Unknown[a](#efs25069-note-0034){ref-type="fn"}   Subtotal non‐infected herds   Total                                                                                                                                   
  ---------------- ---------------- ---------------------------------------------------- ------------------------------------------------ ----------------------------- ----------- -------- ------------ ------------ -------- ------------ ------- ----------- ----------- -------- ----------- ------------- -------------
  **AT**           0                1                                                    0                                                0                             1           0        849          35           0        884          0       0           0           0        0           884           885
  **BE**           0                0                                                    0                                                0                             0           0        558          0            0        558          0       0           0           0        0           558           558
  **BG**           0                0                                                    0                                                0                             0           0        92           1,760        0        1,852        0       0           0           0        0           1,852         1,852
  **CY**           357              0                                                    0                                                0                             357         0        5,781        3,457        0        9,238        0       0           0           0        0           9,238         9,595
  **CZ**           0                0                                                    0                                                0                             0           0        416          0            0        416          0       0           0           0        0           416           416
  **DE**           0                0                                                    0                                                0                             0           0        0            0            0        0            1       1,668       253         8        1,930       1,930         1,930
  **DK**           0                0                                                    0                                                0                             0           0        132          0            0        132          0       0           0           0        0           132           132
  **EE**           0                0                                                    0                                                0                             0           0        0            0            0        0            0       22          0           0        22          22            22
  **EL**           86               0                                                    0                                                0                             86          0        0            0            0        0            0       658         1,164       5        1,827       1,827         1,913
  **ES**           853              0                                                    0                                                0                             853         0        10,128       9,547        0        19,675       0       0           0           0        0           19,675        20,528
  **FI**           0                0                                                    0                                                0                             0           0        132          0            0        132          0       0           0           0        0           132           132
  **FR**           1                0                                                    713                                              0                             714         0        18,003       5,389        0        23,392       0       0           0           0        0           23,392        24,106
  **HR**           0                0                                                    0                                                0                             0           0        346          0            2        348          0       0           0           0        0           348           348
  **HU**           0                0                                                    0                                                0                             0           0        105          56           0        161          0       0           0           0        0           161           161
  **IE**           0                0                                                    0                                                0                             0           0        55           0            0        55           0       78          0           0        78          133           133
  **IT**           559              20                                                   154                                              0                             733         97       7,096        16,785       0        23,978       0       0           0           0        0           23,978        24,711
  **LT**           0                0                                                    0                                                0                             0           0        11           6            0        17           0       0           0           0        0           17            17
  **LU**           0                0                                                    0                                                0                             0           0        95           0            0        95           0       0           0           0        0           95            95
  **LV**           0                0                                                    0                                                0                             0           0        12           0            0        12           0       0           0           0        0           12            12
  **MT**           0                0                                                    0                                                0                             0           0        116          56           0        172          0       0           0           0        0           172           172
  **NL**           0                0                                                    0                                                0                             0           0        0            0            0        0            0       1,528       0           0        1,528       1,528         1,528
  **PL**           0                0                                                    0                                                0                             0           0        3,074        278          0        3,352        0       0           0           0        0           3,352         3,352
  **PT**           0                0                                                    0                                                0                             0           0        0            0            0        0            3       1,508       62          0        1,573       1,573         1,573
  **RO**           0                34                                                   1,113                                            2                             1,149       0        3,602        8,515        1        12,118       0       633         645         0        1,278       13,396        14,545
  **SE**           0                0                                                    0                                                0                             0           0        49           0            0        49           0       0           0           0        0           49            49
  **SI**           0                0                                                    0                                                0                             0           0        657          48           6        711          0       0           0           0        0           711           711
  **SK**           0                0                                                    0                                                0                             0           0        212          0            0        212          0       0           0           0        0           212           212
  **UK**           241              347                                                  50                                               0                             638         0        504          0            2        506          0       0           0           0        0           506           1,144
  **Total EU**     **2,097**        **402**                                              **2,030**                                        **2**                         **4,531**   **97**   **52,025**   **45,932**   **11**   **98,065**   **4**   **6,095**   **2,124**   **13**   **8,236**   **106,301**   **110,832**
  **CH**           0                0                                                    0                                                0                             0           0        0            0            2        2            0       0           0           0        0           2             2
  **IS**           0                0                                                    0                                                0                             0           0        0            0            0        0            0       0           3           0        3           3             3
  **NO**           0                0                                                    0                                                0                             0           0        449          13           1        463          0       0           0           0        0           463           463
  **Total EFTA**   **0**            **0**                                                **0**                                            **0**                         **0**       **0**    **449**      **13**       **3**    **465**      **0**   **0**       **3**       **0**    **3**       **468**       **468**
  **Total**        **2,097**        **402**                                              **2,030**                                        **2**                         **4,531**   **97**   **52,474**   **45,945**   **14**   **98,530**   **4**   **6,095**   **2,127**   **13**   **8,239**   **106,769**   **111,300**

EM: animals culled under TSE eradication measures; NSHC: Animals not slaughtered for human consumption; SHC: animals slaughtered for human consumption; SU: animals clinically suspected of being infected by a TSE.

The 'Other' and 'Unknown' are assumed to be non‐TSE‐infected flocks.

John Wiley & Sons, Ltd

A total of 685 scrapie cases in sheep was reported in the EU in 2016 (Table [13](#efs25069-tbl-0013){ref-type="table"}), similar to the previous year (641 cases). They were reported by 20 MSs. In particular, CS was reported by 9 different MSs and one non‐MS (CY, EL, ES, FR, IE, IT, PT, RO and SK, and in IS), whereas AS was reported by 18 different MSs and one non‐MS (the 9 that reported CS except CY and RO plus AT, BG, CZ, DE, DK, FI, HU, PL, SE, SI and the UK and in NO). About 81.2% of the ovine cases were reported by four countries, namely EL, ES, IT and RO. A total of 554 ovine cases were CS cases (81%), 122 AS (18%) and a few unknown (9 cases). An additional 25 cases of scrapie in sheep were reported by two non‐MSs: 11 CS cases in Iceland and 14 AS cases in Norway. The geographical distribution of AS and CS in sheep is shown in Appendix [D](#efs25069-sec-1004){ref-type="sec"}.

Currently, the reporting in the EU database does not include the number of newly infected flocks and herds during the reporting year. The number of index cases can therefore be considered a proxy for the incidence of scrapie at country level. In sheep in 2016, 32% of all cases were index cases, with a higher proportion (106/122) in atypical scrapie cases than in CS cases (112/554). Using these cases as a proxy for the flock‐level incidence in sheep and comparing 2015 with 2016, there was a slight increase in CS cases (from 109 to 112) and a decrease in AS cases (from 120 to 106).

A total of 634 scrapie cases in goats was reported in the EU in 2016, a 40% reduction compared with 2015 when 1,052 cases were reported. This is due mainly to the decrease in the number of CS scrapie cases in goats in a single reporting country, Cyprus, from 923 in 2015 to 570 in 2016.

Scrapie in goats was reported by nine MSs. In particular, CS was reported by seven MSs (BG, CY, EL, ES, IT, RO and the UK), whereas AS was reported by 5 MSs (EL, ES, FR, IT and PT). As mentioned, most of the cases (89.9%) were reported by Cyprus.

Of the caprine scrapie cases, 621 were CS (98%) and 13 were atypical scrapie (2%) (Table [14](#efs25069-tbl-0014){ref-type="table"}). In goats, the proportion of index cases was 6.8% (13/13 atypical scrapie and 30/621 CS cases). The low proportion is due mainly to Cyprus where many cases in 2016 were still reported from TSE‐infected herds. An improved epidemiological situation is suggested by the low number of new incident cases (only 12 index cases out of 570). Using the index cases in goats as a proxy for the herd‐level incidence and comparing 2015 with 2016, there was a decrease in CS cases (from 37 to 30) and no change in AS cases (13). The geographical distribution of AS and CS in goats is shown in Appendix [D](#efs25069-sec-1004){ref-type="sec"}.

In absolute numbers and without restricting the calculation to index cases, CS is still the most frequently reported type of scrapie in the EU: the CS/AS ratio was 4.5:1 in sheep and 47.8:1 in goats. If CY is excluded, the ratio in goats is similar to that in sheep, i.e. 3.9:1.

###### 

Number of scrapie cases in sheep by country, case type, index case status, surveillance target group in 2016 in the EU and other reporting countries

  Case type         Atypical scrapie (AS)   Classical scrapie (CS)   Unknown   Total                                                                                                                                                                
  ----------------- ----------------------- ------------------------ --------- -------- -------- -------- ------- --------- --------- --------- -------- -------- -------- --------- -------- -------- -------- --------- --------- ------- ------- ---------
  **AT**            0                       0                        0         0        1        0        0       1         **1**     0         0        0        0        0         0        0        0        0         **0**     0       **0**   **1**
  **BG**            0                       0                        0         0        1        1        0       2         **2**     0         0        0        0        0         0        0        0        0         **0**     0       **0**   **2**
  **CY**            0                       0                        0         0        0        0        0       0         **0**     0         3        4        0        7         0        0        0        0         **7**     0       **0**   **7**
  **CZ**            0                       0                        0         0        1        1        0       2         **2**     0         0        0        0        0         0        0        0        0         **0**     0       **0**   **2**
  **DE**            0                       0                        0         0        5        0        0       5         **5**     0         0        0        0        0         0        0        0        0         **0**     0       **0**   **5**
  **DK**            0                       0                        0         0        1        0        0       1         **1**     0         0        0        0        0         0        0        0        0         **0**     0       **0**   **1**
  **EL**            0                       0                        0         0        2        0        0       2         **2**     78        88       2        5        173       32       10       12       54        **227**   0       **0**   **229**
  **ES**            1                       0                        0         1        7        5        0       12        **13**    85        0        0        0        85        3        3        0        6         **91**    0       **0**   **104**
  **FI**            0                       0                        0         0        1        0        1       2         **2**     0         0        0        0        0         0        0        0        0         **0**     0       **0**   **2**
  **FR**            0                       0                        0         0        3        1        0       4         **4**     0         0        0        0        0         1        0        1        2         **2**     0       **0**   **6**
  **HU**            0                       1                        3         4        13       6        0       19        **23**    0         0        0        0        0         0        0        0        0         **0**     0       **0**   **23**
  **IE**            0                       0                        0         0        0        1        0       1         **1**     0         0        0        0        0         1        0        0        1         **1**     0       **0**   **2**
  **IT**            0                       0                        0         0        1        4        0       5         **5**     111       0        0        0        111       12       9        2        23        **134**   9       **9**   **148**
  **PL**            0                       0                        0         0        7        1        0       8         **8**     0         0        0        0        0         0        0        0        0         **0**     0       **0**   **8**
  **PT**            0                       5                        5         10       12       6        0       18        **28**    4         0        0        0        4         3        0        0        3         **7**     0       **0**   **35**
  **RO**            0                       0                        0         0        0        0        0       0         **0**     0         2        2        50       54        6        2        13       21        **75**    0       **0**   **75**
  **SE**            0                       0                        0         0        3        0        0       3         **3**     0         0        0        0        0         0        0        0        0         **0**     0       **0**   **3**
  **SI**            0                       0                        0         0        3        0        0       3         **3**     0         0        0        0        0         0        0        0        0         **0**     0       **0**   **3**
  **SK**            0                       0                        0         0        5        0        0       5         **5**     0         1        7        0        8         1        1        0        2         **10**    0       **0**   **15**
  **UK**            0                       1                        0         1        9        4        0       13        **14**    0         0        0        0        0         0        0        0        0         **0**     0       **0**   **14**
  **Total EU 28**   **1**                   **7**                    **8**     **16**   **75**   **30**   **1**   **106**   **122**   **278**   **94**   **15**   **55**   **442**   **59**   **25**   **28**   **112**   **554**   **9**   **9**   **685**
  **IS**            0                       0                        0         0        0        0        0       0         **0**     8         0        0        1        9         0        0        2        2         **11**    0       **0**   **11**
  **NO**            0                       1                        0         1        6        7        0       13        **14**    0         0        0        0        0         0        0        0        0         **0**     0       **0**   **14**
  **Total EFTA**    0                       1                        0         1        6        7        0       13        **14**    8         0        0        1        9         0        0        2        2         **11**    0       **0**   **25**
  **Total**         **1**                   **8**                    **8**     **17**   **81**   **37**   **1**   **119**   **136**   **286**   **94**   **15**   **56**   **451**   **59**   **25**   **30**   **114**   **565**   **9**   **9**   **710**

EM: animals culled under TSE eradication measures; NSHC: Animals not slaughtered for human consumption; SHC: animals slaughtered for human consumption; SU: animals clinically suspected of being infected by a TSE.

Only the reporting countries in which scrapie cases in sheep were detected in 2016 are mentioned in the table; no cases of scrapie were reported in non‐MS (Switzerland, Iceland and Norway).

John Wiley & Sons, Ltd

###### 

Number of scrapie cases in goats by country, case type, index case status, surveillance target group in 2016 in the EU and other reporting countries

  Case type         Atypical scrapie (AS)   Classical scrapie (CS)   Total                                                                                                 
  ----------------- ----------------------- ------------------------ ------- -------- ------- ------- ------- ------- --------- ------- ------- ------- -------- --------- ---------
  **BG**            0                       0                        0       **0**    0       0       0       0       0         0       2       0       2        **2**     **2**
  **CY**            0                       0                        0       **0**    292     184     82      0       558       9       3       0       12       **570**   **570**
  **EL**            0                       1                        1       **1**    2       3       0       1       6         1       1       3       5        **11**    **12**
  **ES**            2                       3                        5       **5**    14      0       0       0       14        4       1       0       5        **19**    **24**
  **FR**            2                       1                        3       **3**    0       0       0       0       0         0       0       0       0        **0**     **3**
  **IT**            0                       3                        3       **3**    4       0       0       0       4         1       3       0       4        **8**     **11**
  **PT**            1                       0                        1       **1**    0       0       0       0       0         0       0       0       0        **0**     **1**
  **RO**            0                       0                        0       **0**    0       0       0       1       1         0       0       2       2        **3**     **3**
  **UK**            **0**                   **0**                    **0**   **0**    **4**   **2**   **0**   **2**   **8**     **0**   **0**   **0**   **0**    **8**     **8**
  **Total EU 28**   5                       8                        13      **13**   316     189     82      4       **591**   15      10      5       **30**   **621**   **634**

EM: animals culled under TSE eradication measures; NSHC: Animals not slaughtered for human consumption; SHC: animals slaughtered for human consumption; SU: animals clinically suspected of being infected by a TSE.

Only the reporting countries in which scrapie cases in sheep were detected in 2016 are mentioned in the table; no cases of scrapie were reported in non‐MS (Switzerland, Iceland and Norway).

John Wiley & Sons, Ltd

The evolution in the number of scrapie cases detected at EU level is shown for each species in Figure [8](#efs25069-fig-0008){ref-type="fig"}. After the 2006 peak in the number of reported scrapie cases in sheep with 3,507 cases (when the number of tests also peaked), CS cases have decreased from 1,444 in 2011 to 1,016 in 2014, 498 in 2015 and 554 in 2016.

In goats, this trend in CS cases is less clear but is mainly affected by one single MS (CY), where the number of detected cases has consistently declined since the peak in 2013 when 1,672 cases were reported by CY and 1,804 by the EU. However, the total number of cases has decreased consistently since 2013 to 621 in the reporting year.

Figure [9](#efs25069-fig-0009){ref-type="fig"} shows the evolution of the proportion of scrapie cases (per 10,000 tests) by target group in non‐TSE‐infected flocks of sheep and goats, i.e. the main output of the surveillance. As expected for CS, the average number of CS cases per 10,000 in NSHC, i.e. the risk animals, is higher (p‐value \< 0.001) than that in SHC animals both for sheep (4.7 vs 2.8) and goats (3.0 vs 1.7). Looking at AS, a significant difference is detectable only in sheep (4.4 vs 3.4, p‐value \< 0.001).

Focusing on the last 10 years, the EU trend has remained quite stable for both CS and AS, ranging between 2 and 6 cases per 10,000 tested animals. There is no significant trend for ovine CS and AS (p values = 0.2 and 0.51, respectively) and only a slight significant increase in both caprine CS (Beta = 0.06; p value = 0.001) and AS (Beta = 0.06; p value = 0.03). However, the individual national trends may show different patterns (EFSA BIOHAZ Panel, [2014](#efs25069-bib-0005){ref-type="ref"}). In goats, there was a decrease in the number of cases during the last four years.

![Number of scrapie TSE cases in the EU reported by case type in the period 2002--2016 in (A) sheep and (B) goats\
Right‐hand y‐axis: AS (Atypical scrapie); Left‐hand y‐axis: CS (Classical scrapie).](EFS2-15-e05069-g008){#efs25069-fig-0008}

![Proportion of scrapie cases (per 10,000 tests) in the EU in (A) sheep and (B) goats in the period 2002--2016\
Note: This figure is restricted to testing performed in NSHC and SHC target groups from non‐infected flocks or not previously known as infected.NSHC: Animals not slaughtered for human consumption; SHC: animals slaughtered for human consumption; AS: Atypical scrapie; CS: Classical scrapie.](EFS2-15-e05069-g009){#efs25069-fig-0009}

###### 

Total number of classical scrapie cases in sheep by year and country between 2001 and 2016 in the EU and other reporting countries

  Country           2001     2002        2003      2004      2005        2006        2007        2008        2009        2010      2011        2012      2013        2014        2015      2016      Total CS
  ----------------- -------- ----------- --------- --------- ----------- ----------- ----------- ----------- ----------- --------- ----------- --------- ----------- ----------- --------- --------- ------------
  **BE**            0        24          2         10        1           0           1           0           0           0         0           0         0           0           0         0         **38**
  **BG**            0        0           0         0         0           0           0           2           1           3         0           2         0           3           0         0         **11**
  **CY**            0        0           0         17        670         866         803         540         185         49        12          9         8           25          13        7         **3,204**
  **CZ**            0        16          13        10        1           0           0           16          0           0         0           0         0           0           0         0         **56**
  **DE**            0        12          23        43        27          3           6           0           0           1         0           0         0           0           1         0         **116**
  **EL**            0        68          56        34        52          156         344         621         716         616       879         565       601         557         252       227       **5,744**
  **ES**            0        21          29        14        125         57          148         215         87          126       40          33        48          36          69        91        **1,139**
  **FR**            0        245         125       59        70          587         288         85          19          14        5           2         4           28          1         2         **1,534**
  **HU**            0        0           0         0         0           2           4           1           1           0         0           0         1           1           0         0         **10**
  **IE**            0        66          44        56        54          126         79          20          32          22        40          8         7           19          1         1         **575**
  **IT**            0        135         43        24        329         383         197         148         108         104       211         192       260         241         141       143       **2,659**
  **NL**            0        70          63        54        62          84          36          24          4           1         1           0         2           0           0         0         **401**
  **PT**            0        0           0         0         0           0           0           12          0           3         4           1         6           0           0         7         **33**
  **RO**            0        0           0         0         3           7           28          0           8           26        112         127       154         95          98        75        **733**
  **SI**            0        0           0         12        101         42          12          2           3           4         0           0         0           0           0         0         **176**
  **SK**            0        0           4         32        10          9           8           27          0           2         6           0         0           6           3         10        **117**
  **UK**            0        451         436       331       303         252         50          12          12          1         133         6         6           0           2         0         **1,995**
  **Total EU 28**   0        1,108       838       696       1,808       2,574       2,004       1,725       1,176       972       1,443       945       1,097       1,011       581       563       **18,541**
  **IS**            9        12          19        19        9           21          15          57          7           5         0           0         0           2           29        11        **215**
  **NO**            1        1           1         2         0           7           0           0           1           0         0           0         0           0           0         0         **13**
  **Total EFTA**    10       13          20        21        9           28          15          57          8           5         0           0         0           2           29        11        **228**
  **Total**         **10**   **1,121**   **858**   **717**   **1,817**   **2,602**   **2,019**   **1,782**   **1,184**   **977**   **1,443**   **945**   **1,097**   **1,013**   **610**   **574**   **18,769**

Note: Only the reporting countries in which classical scrapie cases in sheep were detected are mentioned in the table.

Since 1 July 2013, according to point 2 of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001 as amended by Regulation (EU) 630/2013, a Member State (MS) can submit a request to the Commission to be recognised as a MS, or zone of a MS, with a negligible risk of classical scrapie (CS). By the end of 2016, MSS that can submit a request based on the data are Belgium, the Czech Republic, Croatia, Estonia, Latvia, Lithuania, Luxembourg, Malta and Poland. MSs with a negligible risk of classical scrapie (CS) are Austria, Denmark, Finland and Sweden.

John Wiley & Sons, Ltd

###### 

Total number of atypical scrapie cases in sheep by year and country between 2002 and 2016 in the EU and other reporting countries

  Country           2002    2003     2004     2005      2006      2007      2008      2009      2010      2011      2012      2013      2014      2015      2016      Total AS
  ----------------- ------- -------- -------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- -----------
  **AT**            0       0        0        0         0         0         0         0         0         4         3         2         2         1         1         **13**
  **BE**            1       0        1        1         3         2         0         0         0         0         0         0         0         0         0         **8**
  **BG**            0       0        0        0         0         0         2         0         0         0         2         0         0         0         2         **6**
  **CZ**            0       0        0        0         0         1         0         0         0         0         0         0         1         3         2         **7**
  **DE**            0       0        0        0         21        9         7         12        12        19        8         7         10        10        5         **120**
  **DK**            0       0        0        0         3         0         2         0         2         5         0         0         0         0         1         **13**
  **EE**            0       0        0        0         0         0         0         0         1         1         0         0         0         0         0         **2**
  **EL**            0       0        0        0         2         1         3         4         1         4         5         3         5         2         2         **32**
  **ES**            0       9        1        3         21        26        23        19        21        19        20        18        6         12        13        **211**
  **FI**            0       0        1        1         2         1         0         0         3         0         1         1         1         0         2         **13**
  **FR**            0       0        0        13        188       174       49        29        30        24        22        10        6         5         4         **554**
  **HR**            0       0        0        0         0         0         0         0         0         0         0         1         0         1         0         **2**
  **HU**            0       0        0        0         5         3         8         15        7         12        11        9         22        14        23        **129**
  **IE**            0       0        2        0         0         2         0         5         2         1         4         4         7         7         1         **35**
  **IT**            0       0        0        7         22        22        8         0         0         7         5         7         2         6         5         **91**
  **NL**            0       0        0        2         0         2         0         0         1         7         5         1         0         0         0         **18**
  **PL**            0       0        0        0         0         0         0         4         2         4         2         5         13        9         8         **47**
  **PT**            0       1        28       71        70        91        78        36        46        40        44        37        20        30        28        **620**
  **SE**            0       4        2        1         8         2         0         2         4         3         3         3         7         3         3         **45**
  **SI**            0       0        0        0         0         0         0         0         2         1         0         1         1         2         3         **10**
  **SK**            0       0        0        0         1         0         0         1         3         4         3         4         3         3         5         **27**
  **UK**            0       0        17       30        68        44        17        26        19        24        28        18        11        17        14        **333**
  **Total EU 28**   **1**   **14**   **52**   **129**   **414**   **380**   **197**   **153**   **156**   **179**   **166**   **131**   **117**   **125**   **122**   **2,336**
  **IS**            0       0        2        0         0         1         1         0         0         1         0         2         0         1         0         **8**
  **NO**            8       14       14       4         8         9         7         12        5         6         6         12        9         10        14        **138**
  **Total EFTA**    8       14       16       4         8         10        8         12        5         7         6         14        9         11        14        **146**
  **Total**         **9**   **28**   **68**   **133**   **422**   **390**   **205**   **165**   **161**   **186**   **172**   **145**   **126**   **136**   **136**   **2,482**

Only the reporting countries in which atypical scrapie cases in sheep were detected are mentioned in the table.
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###### 

Total number of classical scrapie cases in goats by year and country between 2001 and 2016 in the EU and other reporting countries

  Country           2002     2003     2004     2005      2006      2007        2008        2009      2010      2011      2012        2013        2014        2015        2016      Total CS
  ----------------- -------- -------- -------- --------- --------- ----------- ----------- --------- --------- --------- ----------- ----------- ----------- ----------- --------- ------------
  **BG**            0        0        0        0         0         0           0           1         3         0         0           0           0           1           2         **7**
  **CY**            0        0        11       369       470       1,219       1,121       808       342       295       1,102       1,672       1,364       923         570       **10,266**
  **EL**            5        8        12       11        12        58          67          55        65        56        69          68          31          22          11        **550**
  **ES**            1        1        0        10        6         15          4           6         5         10        3           2           8           16          19        **106**
  **FI**            4        0        0        4         0         0           0           0         0         0         0           0           0           0           0         **8**
  **FR**            15       9        4        8         14        3           14          9         22        0         5           25          0           40          0         **168**
  **IT**            1        3        2        6         12        4           1           13        4         5         7           7           7           21          8         **101**
  **RO**            0        0        0        0         0         2           0           0         0         0         1           3           1           1           3         **11**
  **SI**            0        0        0        4         0         0           0           0         0         0         0           0           0           0           0         **4**
  **UK**            0        0        0        4         13        62          37          6         8         9         21          16          26          16          8         **226**
  **Total EU 28**   26       21       29       416       527       1,363       1,244       898       449       375       1,208       1,793       1,437       1,040       621       **11,447**
  **IS**            0        0        0        0         0         0           0           0         0         0         0           0           0           0           0         **0**
  **NO**            0        0        0        0         0         0           0           0         0         0         0           0           0           0           0         **0**
  **Total EFTA**    0        0        0        0         0         0           0           0         0         0         0           0           0           0           0         **0**
  **Total**         **26**   **21**   **29**   **416**   **527**   **1,363**   **1,244**   **898**   **449**   **375**   **1,208**   **1,793**   **1,437**   **1,040**   **621**   **11,447**

Only the reporting countries in which classical scrapie cases in goats were detected are mentioned in the table.
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###### 

Total number of atypical scrapie cases in goats by year and country between 2005 and 2016 in the EU and other reporting countries

  Country           2005    2006    2007     2008     2009    2010     2011     2012     2013     2014     2015     2016     Total AS
  ----------------- ------- ------- -------- -------- ------- -------- -------- -------- -------- -------- -------- -------- ----------
  **AT**            0       0       0        0        0       0        0        0        0        1        0        0        **1**
  **CY**            0       0       0        0        0       0        0        0        0        0        1        0        **1**
  **DE**            0       0       0        0        0       0        0        0        0        1        0        0        **1**
  **EL**            0       0       0        0        0       0        0        0        1        1        1        1        **4**
  **ES**            0       4       6        5        2       5        3        3        4        7        5        5        **49**
  **FI**            0       0       0        0        1       0        0        0        0        0        0        0        **1**
  **FR**            6       1       5        8        3       5        6        6        3        5        5        3        **56**
  **IT**            3       3       3        1        0       0        4        0        3        0        1        3        **21**
  **PT**            0       0       1        1        3       2        1        2        2        0        0        1        **13**
  **SI**            0       0       0        0        0       0        0        0        0        0        1        0        **1**
  **Total EU 28**   9       8       15       15       9       12       14       11       13       15       14       13       **148**
  **NO**            0       1       0        0        0       0        0        0        0        0        0        0        **1**
  **Total EFTA**    0       1       0        0        0       0        0        0        0        0        0        0        **1**
  **Total**         **9**   **9**   **15**   **15**   **9**   **12**   **14**   **11**   **13**   **15**   **14**   **13**   **149**

Only the reporting countries in which atypical scrapie cases in goats were detected are mentioned in the table.

John Wiley & Sons, Ltd

Tables [15](#efs25069-tbl-0015){ref-type="table"} and [16](#efs25069-tbl-0016){ref-type="table"} show the cases of classical and atypical scrapie, respectively, in sheep between 2002 and 2016. For this period, the annual CS:AS ratio was calculated and plotted for each reporting country (see Appendix [B](#efs25069-sec-1002){ref-type="sec"}). Figure [10](#efs25069-fig-0010){ref-type="fig"} shows the CS:AS ratio for three groups of countries aggregated based on the pattern of the CS:AS ratio: (1) countries with a CS:AS ratio that is always below one (more AS than CS cases have consistently been detected): AT, BE, DK, EE, FI, HR, PL, PT and SE; (2) countries with a decreasing CS:AS ratio over time (crossing the ratio of one at some point): BG, the CZ, DE, FR, HU, IE, the NL, NO, SK, SI, and the UK; (3) countries with a CS:AS ratio that is always greater than one (more CS than AS cases have consistently been detected): CY, EL, ES, IS, IT and RO.

Tables [17](#efs25069-tbl-0017){ref-type="table"} and [18](#efs25069-tbl-0018){ref-type="table"} show the cases of classical and atypical scrapie, respectively, in goats between 2002 and 2016.

![Evolution of the ratio of CS:AS cases in the period 2002--2016 in three distinct patterns\
Only data from cases in sheep are considered. The CS:AS ratio\'s for the three groups of countries were calculated by aggregating the number of CS and AS cases for each year over the countries per group. Positive values of the CS:AS in a certain year show how many times CS cases were more frequently detected than AS cases. At CS:AS ratio equals to one, the number of CS and AS cases are equal in number.](EFS2-15-e05069-g010){#efs25069-fig-0010}

Figure [11](#efs25069-fig-0011){ref-type="fig"} shows the average age of the TSE cases confirmed in sheep (A) and goats (B) by case type. In sheep, the average age of AS cases (79.9 months, standard error (SE): 0.83) is significantly higher (p‐value \< 0.001) than that of CS cases (46.0, SE: 0.17). Similarly, in goats the average age of AS cases (81.9 months, SE: 3.4) is statistically higher (p‐value \< 0.001) than in CS cases (50.4 months, SE: 0.21). When comparing sheep with goats, there is no difference in the average age for AS (p‐value = 0.56), whereas the average age for CS in sheep was significantly lower than for goats (p‐value \< 0.01).

![Average age of TSE cases confirmed in sheep (A) and goats (B) by case type and year for the period 2002--2016\
AS: atypical scrapie; CS: classical scrapie.](EFS2-15-e05069-g011){#efs25069-fig-0011}

Tables [19](#efs25069-tbl-0019){ref-type="table"} and [20](#efs25069-tbl-0020){ref-type="table"} summarises by reporting country the number of cases subjected to discriminatory testing in 2016 for sheep and goats respectively. In sheep, 465 (82.6%) of the CS or unknown cases were submitted for discriminatory testing. In sheep, apart for a small proportion of inconclusive results (9 from IT), all scrapie cases submitted for discriminatory testing were confirmed as being CS cases (BSE excluded). In goats, 70 (11.3%) of the CS or unknown cases were submitted for discriminatory testing. All goat cases subjected to discriminatory testing (70) were CS cases.

###### 

Number of cases subjected to discriminatory testing in sheep by reporting country, 2016

  Sheep                                           Cases submitted for discriminatory testing   Cases not submitted for discriminatory testing or blank                                                                                 
  ----------------- --------- --------- --------- -------------------------------------------- --------------------------------------------------------- ------- --------- ----------- ----------------------------------------------- -----
  **AT**            1         0         1         0                                            0                                                         0       0         100.0%      0.0%                                            1
  **BG**            2         0         2         0                                            2                                                         0       2         0.0%        100.0%[b](#efs25069-note-0045){ref-type="fn"}   0
  **CY**            7         7         0         0                                            0                                                         0       0         0.0%        0.0%                                            7
  **CZ**            2         0         2         0                                            2                                                         0       2         0.0%        100.0%[b](#efs25069-note-0045){ref-type="fn"}   0
  **DE**            5         0         5         0                                            0                                                         0       0         100.0%      0.0%                                            5
  **DK**            1         0         1         0                                            0                                                         0       0         100.0%      0.0%                                            1
  **EL**            229       227       2         0                                            114                                                       0       114       50.2%       0.0%                                            115
  **ES**            104       91        13        0                                            104                                                       0       104       114.3.%     100.0%[b](#efs25069-note-0045){ref-type="fn"}   0
  **FI**            2         0         2         0                                            0                                                         0       0         100.0%      0.0%                                            2
  **FR**            6         2         4         0                                            2                                                         0       2         100.0%      0.0%                                            4
  **HU**            23        0         23        0                                            0                                                         0       0         100.0%      0.0%                                            23
  **IE**            2         1         1         0                                            1                                                         0       1         100.0%      0.0%                                            1
  **IT**            148       143       5         0                                            139                                                       9       148       103.4%      0.0%                                            0
  **PL**            8         0         8         0                                            0                                                         0       0         100.0%      0.0%                                            8
  **PT**            35        7         28        0                                            7                                                         0       7         100.0%      0.0%                                            28
  **RO**            75        75        0         0                                            75                                                        0       75        100.0%      0.0%                                            0
  **SE**            3         0         3         0                                            0                                                         0       0         100.0%      0.0%                                            3
  **SI**            3         0         3         0                                            0                                                         0       0         100.0%      0.0%                                            3
  **SK**            15        10        5         0                                            10                                                        0       10        100.0%      0.0%                                            5
  **UK**            14        0         14        0                                            0                                                         0       0         100.0%      0.0%                                            14
  **Total EU 28**   **685**   **563**   **122**   **0**                                        **456**                                                   **9**   **465**   **82.6%**   **13.9%**                                       220
  **IS**            11        11        0         0                                            11                                                        0       11        100.0%      0.0%                                            0
  **NO**            14        0         14        0                                            0                                                         0       0         100.0%      0.0%                                            14
  **Total EFTA**    **25**    **11**    **14**    **0**                                        **11**                                                    **0**   **11**    100.0%      0.0%                                            14
  **Total Sheep**   **710**   **574**   **136**   **0**                                        **467**                                                   **9**   **476**   **82.9%**   **12.5%**                                       234

Note: Only the reporting countries in which scrapie cases were detected in 2016 are mentioned in the table.

Indicates the proportion of classical TSE cases that are submitted to discriminatory testing by each MS.

Indicates the proportion of atypical TSE cases that are submitted to discriminatory testing by each MS; Bulgaria, the Czech Republic and Spain submitted, respectively, 2, 2 and 13 atypical scrapie cases for discriminatory testing.

John Wiley & Sons, Ltd

###### 

Number of cases subjected to discriminatory testing in goats by reporting country, 2016

  Goats                                          Cases submitted for discriminatory testing   Cases not submitted for discriminatory testing or blank                                            
  ----------------- --------- --------- -------- -------------------------------------------- --------------------------------------------------------- ------- -------- ----------- ----------- ---------
  **BG**            2         2         0        0                                            2                                                         0       2        100.0%      0.0%        0
  **CY**            570       570       0        0                                            13                                                        0       13       2.3%        0.0%        557
  **EL**            12        11        1        0                                            9                                                         0       9        81.2%       0.0%        3
  **ES**            24        19        5        0                                            24                                                        0       24       126.3%      100.0%      0
  **FR**            3         0         3        0                                            0                                                         0       0        100.0%      0.0%        3
  **IT**            11        8         3        0                                            11                                                        0       11       137.5%      100.0%      0
  **PT**            1         0         1        0                                            0                                                         0       0        100.0%      0.0%        1
  **RO**            3         3         0        0                                            3                                                         0       3        100.0%      0.0%        0
  **UK**            8         8         0        0                                            8                                                         0       8        100.0%      0.0%        0
  **Total EU 28**   **634**   **621**   **13**   **0**                                        **70**                                                    **0**   **70**   **11.3%**   **61.5%**   **564**

Note: Only the reporting countries in which scrapie cases were detected in 2016 are mentioned in the table.

Indicates the proportion of classical TSE cases that are submitted to discriminatory testing by each MS.

Indicates the proportion of atypical TSE cases that are submitted to discriminatory testing by each MS; Spain and Italy submitted respectively 5 and 3 atypical scrapie cases for discriminatory testing.
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### 3.2.1. Genotyping in sheep {#efs25069-sec-0021}

In sheep, according to Regulation (EC) 999/2001 Annex III, Chapter A, Part I, point 8, the genotype, and, where possible, the breed of each positive case (according to point 8.1) should be determined. A random sample of ovine animals (according to point 8.2) should also be genotyped.

The classification of genotypes according to Great Britain\'s National Scrapie Plan (NSP) is summarised in Table [21](#efs25069-tbl-0021){ref-type="table"}. A three‐tier classification is also reported, as described in Section [2](#efs25069-sec-0013){ref-type="sec"}, in order to show the evolution of the genotype distribution in sheep populations within the EU.

###### 

Classification of the genotypes of the sheep *PRNP* gene according to Great Britain\'s National Scrapie Plan (NSP) and the three‐tiers of report groups

  NSP group            Genotype                                      Comment                                                                 Report group
  -------------------- --------------------------------------------- ----------------------------------------------------------------------- ----------------
  NSP1                 ARR/ARR                                       Genetically most resistant                                              Resistant
  NSP2                 ARR/ARQ; ARR/ARH; ARR/AHQ                     Genetically resistant                                                   Semi‐resistant
  NSP3                 ARQ/ARQ                                       Genetically little resistant (ARQ/ARQ may be scientifically reviewed)   Susceptible
  NSP3 Other (NSP3O)   AHQ/AHQ; ARH/ARH; ARH/ARQ; AHQ/ARH; AHQ/ARQ                                                                           Susceptible
  NSP4                 ARR/VRQ                                       Genetically susceptible                                                 Susceptible
  NSP5                 ARQ/VRQ; ARH/VRQ; AHQ/VRQ; VRQ/VRQ            Genetically highly susceptible                                          Susceptible

John Wiley & Sons, Ltd

Table [22](#efs25069-tbl-0022){ref-type="table"} shows the genotypes of ovine scrapie cases in 2016 in the EU and other reporting countries.

###### 

Distribution of genotypes of confirmed scrapie cases in sheep in 2016 by reporting country and National Scrapie Plan (NSP) group

  NSP group         Atypical scrapie   Classical scrapie                                                                                                                      
  ----------------- ------------------ ------------------- -------- -------- ------- ------- -------- --------- ------- -------- --------- -------- ------- -------- -------- ---------
  **AT**            0                  1                   0        0        0       0       0        **1**     0       0        0         0        0       0        0        **0**
  **BG**            0                  0                   0        0        0       0       2        **2**     0       0        0         0        0       0        0        **0**
  **CY**            0                  0                   0        0        0       0       0        **0**     0       5        1         0        0       0        1        **7**
  **CZ**            0                  0                   1        0        0       0       1        **2**     0       0        0         0        0       0        0        **0**
  **DE**            0                  1                   0        0        0       0       2        **3**     0       0        0         0        0       0        0        **0**
  **DK**            0                  0                   0        0        0       0       1        **1**     0       0        0         0        0       0        0        **0**
  **EL**            0                  1                   0        1        0       0       0        **2**     0       3        165       42       1       13       3        **227**
  **ES**            3                  2                   4        3        0       0       1        **13**    0       1        83        1        0       1        5        **91**
  **FI**            0                  0                   1        1        0       0       0        **2**     0       0        0         0        0       0        0        **0**
  **FR**            0                  0                   2        0        0       0       2        **4**     0       0        1         0        0       1        0        **2**
  **HU**            3                  13                  3        4        0       0       0        **23**    0       0        0         0        0       0        0        **0**
  **IE**            0                  0                   1        0        0       0       0        **1**     0       1        0         0        0       0        0        **1**
  **IT**            0                  1                   2        2        0       0       0        **5**     0       0        117       16       0       1        0        **134**
  **PL**            1                  4                   1        1        0       0       1        **8**     0       0        0         0        0       0        0        **0**
  **PT**            2                  3                   10       4        1       2       6        **28**    0       0        5         0        0       1        1        **7**
  **RO**            0                  0                   0        0        0       0       0        **0**     0       4        50        3        1       17       0        **75**
  **SE**            0                  0                   0        0        0       0       3        **3**     0       0        0         0        0       0        0        **0**
  **SI**            1                  0                   2        0        0       0       0        **3**     0       0        0         0        0       0        0        **0**
  **SK**            1                  2                   1        1        0       0       0        **5**     0       1        5         1        0       3        0        **10**
  **UK**            1                  2                   0        9        0       0       2        **14**    0       0        0         0        0       0        0        **0**
  **Total EU 28**   **12**             **30**              **28**   **26**   **1**   **2**   **21**   **120**   **0**   **15**   **427**   **63**   **2**   **37**   **10**   **554**
  **CH**            0                  0                   0        0        0       *0*     0        **0**     0       0        0         0        0       *0*      0        **0**
  **IS**            0                  0                   0        0        0       0       0        **0**     0       0        9         0        0       2        0        **11**
  **NO**            2                  4                   2        5        0       0       1        **14**    0       0        0         0        0       *0*      0        **0**
  **Total EFTA**    **2**              **4**               **2**    **5**    **0**   **0**   **1**    **14**    **0**   **0**    **9**     **0**    **0**   **2**    **0**    **11**
  **Total**         **14**             **34**              **30**   **31**   **1**   **2**   **22**   **134**   **0**   **15**   **436**   **63**   **2**   **39**   **10**   **565**
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![Frequency distribution of genotypes of sheep scrapie cases by case type, year and NSP group in the period 2002--2016 in the reporting countries\
(A) Atypical scrapie. (B) Classical scrapie.](EFS2-15-e05069-g012){#efs25069-fig-0012}

In total, 529 (97.2%) of the 544 cases of CS in sheep with known genotype reported in the EU in 2016 (Table [22](#efs25069-tbl-0022){ref-type="table"}) were from the susceptible genotype groups (NSP3, NSP3O, NSP4 and NSP5), consistent with the pattern observed in all cases reported since 2002 (Figure [12](#efs25069-fig-0012){ref-type="fig"}). For AS, the same genotype groups accounted for 57.6% of all cases.

Table [23](#efs25069-tbl-0023){ref-type="table"} shows the genotypes obtained in 2016 from the random samples of tested sheep in the reporting countries. In the EU, excluding data from Cyprus (where genotyping is conducted systematically in the sheep population), 26.6% of the sheep population is susceptible to CS (i.e. belongs to groups NSP3, NSP3O, NSP4 or NSP5).

Considering the past 5 years of random sampling, the resistant genotype group (NSP1; black colour in the bars of Figure [13](#efs25069-fig-0013){ref-type="fig"}) accounts for between 29.8% (in 2012) and 50.6% (in 2015) of the total number of sheep genotyped (Table [22](#efs25069-tbl-0022){ref-type="table"} and Figure [13](#efs25069-fig-0013){ref-type="fig"}).

###### 

Distribution of genotypes in randomly selected sheep in the EU and other reporting countries in 2016 by Member State and National Scrapie Plan (NSP) group, in accordance with Regulation (EC) 999/2001 Annex III, Chapter A, Part I, point 8.2

  Country                                          Number of genotyped animals (% of sample within country)                                                                                                               
  ------------------------------------------------ ---------------------------------------------------------- ------------------- ------------------ ----------------- ---------------- ---------------- ---------------- ------------
  **AT**                                           10 (9.4%)                                                  39 (36.8%)          40 (37.7%)         11 (10.3%)        1(1.0%)          3 (2.8%          2 (1.8%)         106
  **BE**                                           159 (63.9%)                                                57 (22.9%)          13 (5.2%)          7 (2.8%)          2 (0.8%)         4 (1.6%)         7 (2.8%)         249
  **BG**                                           --                                                         --                  --                 --                --               --               --               --
  **CY** [a](#efs25069-note-0051){ref-type="fn"}   47,775 (86.5%)                                             6,099 (11.0%)       280 (0.5%)         118 (0.2%)        432 (0.8%)       45 (0.1%)        464 (0.8%)       55,213
  **CZ**                                           6 (22.2%)                                                  13 (48.1%)          6 (22.2%)          1 (3.7%)          0 (0.0%)         1 (3.7%)         0 (0.0%)         27
  **DE**                                           1,268 (76.2%)                                              261 (15.7%)         75 (4.5%)          15 (0.9%)         41 (2.5%)        1 (0.1%)         2 (0.1%)         1,663
  **DK**                                           36 (36.0%)                                                 15 (15.0%)          28 (28.0%)         13 (13.0%)        0 (0.0%)         8 (8.0%)         0 (0.0%)         100
  **EE**                                           30 (30.0%)                                                 45 (45.0%)          10 (10.0%)         5 (5.0%)          5 (5.0%)         5 (5.0%)         0 (0.0%)         100
  **EL**                                           47 (13.1%)                                                 112 (31.3%)         121 (33.8%)        38 (10.6%)        8 (2.2%)         12 (3.4%)        20 (5.6%)        358
  **ES**                                           76 (11.6%)                                                 263 (40.1%)         218 (33.2%)        44 (6.7%)         7 (1.1%)         22 (3.4%)        26 (4.0%)        656
  **FI**                                           2 (2.0%)                                                   25 (25.0%)          45 (45.0%)         11 (11.0%)        4 (4.0%)         13 (13.0%)       0 (0.0%)         100
  **FR**                                           315 (49.5%)                                                184 (28.9%)         55 (8.6%)          5(0.8%)           8 (1.3%)         13 (2.0%)        57 (8.9%)        637
  **HR**                                           13 (8.7%)                                                  56 (37.3%)          59 (39.3%)         22 (14.7%)        0 (0.0%)         0 (0.0%)         0 (0.0%)         150
  **HU**                                           357 (59.5%)                                                186 (31.0%)         24 (4.0%)          21 (3.5%)         6 (1.0%)         6 (1.0%)         0 (0.0%)         600
  **IE**                                           249 (37.3%)                                                256 (38.3%)         65 (9.7%)          45 (6.7%)         31 (4.6%)        22 (3.3%)        0 (0.0%)         668
  **IT**                                           119 (19.5%)                                                269 (44.1%)         175 (28.7%)        25 (4.1%)         8 (1.3%)         10 (1.6%)        4 (0.7%)         610
  **LT**                                           29 (29.6%)                                                 40 (40.8%)          23 (23.5%)         4 (4.1%)          0 (0.0%)         1 (1.0%)         1 (1.0%)         98
  **LU**                                           63 (63.0%)                                                 21 (21.0%)          4 (4.0%)           2 (2.0%)          5 (5.0%)         5 (5.0%)         0 (0.0%)         100
  **LV**                                           18 (16.5%)                                                 49 (45.0%)          38 (34.9%)         2 (1.8%)          0 (0.0%)         2 (1.8%)         0 (0.0%)         109
  **MT**                                           --                                                         --                  --                 --                --               --               --               --
  **NL**                                           562 (64.2%)                                                216 (24.7%)         31 (3.5%)          40 (4.6%)         17 (1.9%)        10 (1.1%)        0 (0.0%)         876
  **PL**                                           43 (38.1%)                                                 46 (40.7%)          16 (14.2%)         3 (2.7%)          3 (2.7%)         2 (1.8%)         0 (0.0%)         113
  **PT**                                           105 (16.9%)                                                244 (39.3%)         185 (29.8%)        48 (7.7%)         16 (2.6%)        23 (3.7%)        0 (0.0%)         621
  **RO**                                           55 (10.2%)                                                 225 (41.6%)         174 (32.2%)        40 (7.4%)         14 (2.6%)        33 (6.1%)        0 (0.0%)         541
  **SE**                                           10 (10.0%)                                                 13 (13.0%)          66 (66.0%)         3 (3.0%)          1 (1.0%)         7 (7.0%)         0 (0.0%)         100
  **SI**                                           6 (4.6%)                                                   45 (34.4%)          60 (45.8%)         13 (9.9%)         2 (1.5%)         5 (3.8%)         0 (0.0%)         131
  **SK**                                           32 (32.0%)                                                 42 (42.0%)          12 (12.0%)         4 (4.0%)          7 (7.0%)         3 (3.0%)         0 (0.0%)         100
  **UK**                                           228 (38.0%)                                                261 (43.5%)         42 (7.0%)          54 (9.0%)         7 (1.2%)         8 (1.3%)         0 (0.0%)         600
  **Total EU 28**                                  **51,613 (79.9%)**                                         **9,082 (14.1%)**   **1,865 (2.9%)**   **594 (0.9%)**    **625 (1.0%)**   **264 (0.4%)**   **583 (0.9%)**   **64,626**
  **CH**                                           --                                                         --                  --                 --                --               --               --               --
  **IS**                                           0 (0.0%)                                                   0 (0.0%)            212 (70.0%)        51 (16.8%)        0 (0.0%)         40 (13.2%)       0 (0.0%)         303
  **NO**                                           69 (11.7%)                                                 228 (38.6%)         106 (18.0%)        103 (17.5%)       37 (6.3%)        47 (8.0%)        0 (0.0%)         590
  **Total EFTA**                                   **69 (7.7%)**                                              **228 (25.5%)**     **318 (35.6%)**    **154 (17.2%)**   **37 (4.1%)**    **87 (9.7%)**    **0 (0.0%)**     **893**
  **Total**                                        **51,682 (78.9%)**                                         **9,310 (14.2%)**   **2,183 (3.3%)**   **748 (1.1%)**    **662 (1.0%)**   **351 (0.5%)**   **583 (0.9%)**   **65,516**

--: no genotyping performed in 2016.

The Cyprus data are different from those of other Member States as CY systematically genotypes the breeding sheep population.

John Wiley & Sons, Ltd

![Frequency distribution of the three genotype groups in sheep sampled for genotyping in the EU in the period 2002--2016 according to Regulation (EC) 999/2001 Annex III, Chapter A, Part I, point 8.2\
Data from Cyprus were excluded. NSP1: Resistant (black); NSP2: Semi‐Resistant (grey); NSP3+NSP3O+NSP4+SNP5: Susceptible (white). (As referred to in Table [21](#efs25069-tbl-0021){ref-type="table"}).](EFS2-15-e05069-g013){#efs25069-fig-0013}

3.3. Other species {#efs25069-sec-0022}
------------------

In 2016, 2,712 cervids (Table [24](#efs25069-tbl-0024){ref-type="table"}) were tested by seven MSs, with Romania accounting for more than 90% (2,500 wild cervids were tested). The animals were almost exclusively from wild populations even though no information is available on the design of the surveillance carried out. All animals tested negative.

In 2016, the first case of CWD in Europe was detected in a Norwegian free‐ranging reindeer (Benestad et al., [2016](#efs25069-bib-0001){ref-type="ref"}). In April and May of 2016, Norway confirmed two additional cases of CWD, one in a wild reindeer and one in a wild moose. In light of this emerging issue, NO intensified its monitoring for CWD in wild and captive cervids and tested during 2016 10,139 deer. The total number of cases confirmed in 2016 was 5: 3 in wild Eurasian tundra reindeer and 2 in wild moose.

In parallel with the monitoring of cervids in 2016, four MSs (DK, EE, FI and HU) reported results on samples tested for TSE in species other than ruminants. In total, 490 samples were collected from the following species: cat (*Felis catus*) (76.9%), mink (*Mustela lutreola*) (13.9%), fox (genus *Vulpes*) (7.1%) and racoon dogs (*Nyctereutes procyonoides*) (2%). None tested positive (Table [25](#efs25069-tbl-0025){ref-type="table"}).

###### 

Number of cervids tested in the reporting countries in 2016 by species, management system and country (number of positives for CWD in brackets)

                   Wild deer                                        Domesticated/farmed deer                                                                                                                                                                                                    
  ---------------- ------------------------------------------------ -------------------------- -------------------------------------------------- --------- -------- ----------- ------- ----------- ---------------- ----------- ------- ------- ------- ------- --------- ------- ----------- ------------
  **AT**           0                                                0                          0                                                  0         0        1           0       0           **1**            0           0       0       0       0       1         0       **1**       **2**
  **EE**           0                                                0                          1                                                  0         0        0           0       0           **1**            0           0       0       0       0       0         0       **0**       **1**
  **FI**           0                                                5                          26                                                 7         12       0           0       0           **50**           6           0       0       0       0       0         0       **6**       **56**
  **HU**           0                                                0                          0                                                  6         0        1           1       **1**       **9**            0           0       0       0       0       0         0       **0**       **9**
  **IT**           0                                                0                          0                                                  49        0        24          1       0           **74**           0           0       0       0       0       0         0       **0**       **74**
  **RO**           0                                                0                          0                                                  0         0        459         7       **2,034**   **2,500**        0           0       0       0       0       0         0       **0**       **2,500**
  **SE**           0                                                0                          60                                                 7         0        3           0       0           **70**           0           0       0       0       0       0         0       **0**       **70**
  **Total EU**     **0**                                            **5**                      **87**                                             **69**    **12**   **488**     **9**   **2,035**   **2,705**        **6**       **0**   **0**   **0**   **0**   **1**     **0**   **7**       **2,712**
  **NO**           842 (3)[a](#efs25069-note-0052){ref-type="fn"}   0                          4,403 (2)[a](#efs25069-note-0052){ref-type="fn"}   473       0        2,451       0       **88**      **8,257**        1,739       0       0       0       0       143       0       **1,882**   **10,139**
  **IS**           13                                               0                          0                                                  0         0        0           0       0           **13**           1           0       0       0       0       0         0       **1**       **14**
  **Total EFTA**   **855 (3)**                                      **0**                      **4,403 (2)**                                      **473**   **0**    **2,451**   **0**   **0**       **8,270 (5)**    **1,740**   **0**   **0**   **0**   **0**   **143**   **0**   **1,883**   **10,153**
  **Total**        **855 (3)**                                      **5**                      **4,490 (2)**                                      **542**   **12**   **2,939**   **9**   **2,123**   **10,975 (5)**   **1,746**   **0**   **0**   **0**   **0**   **144**   **0**   **1,890**   **12,865**

3 out of 842 tested wild Eurasian tundra reindeer were found positive as well as 2 out of 4,403 tested wild moose.
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###### 

Numbers of tests[a](#efs25069-note-0053){ref-type="fn"} for TSE in species other than ruminants in EU Member States in 2016

  Country        Wild ruminants   Raccoon dogs (*Nyctereutes procyonoides*)   Fox (genus *Vulpes*)   Minks (*Mustela lutreola*)   Cats (*Felis catus*)   Total
  -------------- ---------------- ------------------------------------------- ---------------------- ---------------------------- ---------------------- -------
  **DK**         0                0                                           0                      0                            **7**                  7
  **EE**         0                0                                           0                      14                           **0**                  14
  **FI**         0                10                                          35                     54                           **59**                 158
  **HU**         0                0                                           0                      0                            **311**                311
  **Total EU**   0                10                                          35                     68                           **377**                490

All tests were negative.

John Wiley & Sons, Ltd

4. Conclusions {#efs25069-sec-0023}
==============

Since 2001, ca.115 million cattle have been tested for BSE in the EU, with a sustained decrease in the number of animals tested over time following amendments to the TSE Regulation. In 2016, despite the 5% reduction in the number of cattle tested, the number of samples tested from risk animals (AM + ES + FS) over 48 months of age showed an increase (+ 28,118) compared with 2015.

The decline of C‐BSE has been consistent over the past decade in terms of the absolute number of cases and the proportion of cases in tested animals. Focusing on the last 10 years, the decreasing trend for C‐BSE is statistically significant, whereas no significant trend (either increasing or decreasing) is observed for H‐BSE or L‐BSE.

In 2016, only two MSs (France and Spain) reported cases of BSE: five in total. Of the five cases that were reported, four were atypical BSE (all H‐type), three from FR and one from ES. The fifth case was a C‐BSE detected in France in a beef cow born in 2011, i.e. 10 years after the EU‐wide reinforced feed ban of 2001 (BARB case), reported as fallen stock. For the first time since BSE cases have been reported, no C‐BSE or atypical BSE cases were reported by the United Kingdom in 2016.

Since 2002, ca. 8.8 million small ruminants have been tested as part of the EU‐wide TSE surveillance. There have been a 5% and 11% reduction in the number of sheep and goats tested in 2016, respectively. The reduction was observed in reported 'non‐infected flocks' category since the total number of small ruminants tested in the 'infected flocks' category remained stable at around 15,000 sheep and 4,500 goats. The requirements for testing a minimum number of samples from the SHC and NSHC surveillance target groups in the small ruminant populations were fulfilled by 23 MSs for sheep and by 17 MSs for goats.

In 2016, four countries (Greece, Spain, Italy and Romania) accounted for 95% of all CS sheep cases and 81.2% of all cases. CS was reported in sheep by 9 MSs and one non‐MS, whereas AS was reported in sheep by 18 MSs and one non‐MSs.

Cyprus accounted for 90% of all goat cases in 2016. Despite the large caseload from this MS, an improvement in the scrapie situation in Cyprus compared with 2015 is suggested by the 40% decrease in the total number of classical scrapie cases in 2016 (from 923 to 570) and in the number of index cases (from 18 to 12). CS was reported in goats by seven MSs and one non‐MS, whereas AS was reported by five MSs and one non‐MSs. The average age of AS cases is statistically significantly higher than that of CS cases in both sheep and goats (p \< 0.001). There is no significant difference in the average age for AS between sheep and goats (p = 0.56) but the average age for CS in sheep was significantly lower than for goats.

In the EU, the occurrence of scrapie in 2016 was similar to 2015. Using the number of index cases as a proxy for incidence, there has not been a major change. In sheep, the number of CS index cases in 2016 was 112 compared with 109 in 2015, and the number of index cases of AS slightly decreased from 120 in 2015 to 106 in 2016. In goats, the number of CS index cases in 2016 was 30 compared with 37 in 2015, whereas the number of AS index cases was unchanged at 13. Focusing on the last 10 years in the EU, scrapie in sheep has remained quite stable overall for both CS and AS, ranging between 2 and 6 cases per 10,000 tested animals. Overall and for all MS, there has not been a significant trend in ovine CS and AS during that period (p‐values of 0.2 and 0.51, respectively). Focusing on the last 10 years in the EU in goats, a slightly but significant increasing trend in both CS and AS (p‐values of 0.001 and 0.03 respectively) has been observed. However, the last four years a decrease was observed in number of scrapie cases in goats. The individual national trends for scrapie in small ruminants may show different patterns compared with the overall trend in the EU. In absolute numbers, CS is still the most prevalent type of TSE in the European small ruminant population.

With regard to the occurrence of CS compared with that of AS in sheep at MS level in the period 2006--2016, three different patterns can be observed: (a) in nine MSs (Austria, Belgium, Croatia, Denmark, Estonia, Finland, Poland, Portugal and Sweden), the occurrence of CS was always lower than that of AS (the ratio CS:AS was always below one), either because there were more AS than CS cases, or because CS was never reported; (b) in 10 MSs (Bulgaria, the Czech Republic, Germany, France, Hungary, Ireland, the Netherlands, Slovenia, Slovakia and the United Kingdom), the ratio CS:AS was decreasing; (c) in five MSs (Cyprus, Greece, Spain, Italy and Romania), the ratio CS:AS was always above one because there were more CS than AS cases.

The genotyping data collected from the 2016 ovine CS cases consistently confirms the association between the occurrence of the disease and the susceptible genotypes, with 97.2% of the cases having susceptible genotypes (NSP3, NSP3O, NSP4 or NSP5). In 2016, the genotyping data from random samples of the EU sheep population (excluding Cyprus) showed that 26.6% of the genotyped sheep held genotypes of the susceptible group.

In 2016, CWD was detected for the first time in Europe, in Norway (Benestad et al., [2016](#efs25069-bib-0001){ref-type="ref"}; EFSA BIOHAZ Panel, [2017b](#efs25069-bib-0007){ref-type="ref"}), where 10,139 cervids were tested and 5 cases confirmed in two different species: 3 in wild reindeer and 2 in moose. In 2016, 2,712 cervids were tested in seven MSs, but most of them in a single MS (2,500 in Romania), all with negative results. A total of 490 samples from non‐ruminant species were also collected and tested as part of TSE surveillance, all of them with negative results.

Abbreviations {#efs25069-sec-0024}
=============

AM*Ante‐mortem*ASatypical scrapieBARBBorn After the Revised feed BanBSEbovine spongiform encephalopathyC‐BSEclassical bovine spongiform encephalopathyCSclassical scrapieCWDchronic wasting diseaseEFTAEuropean Free Trade AssociationELISAenzyme‐linked immunosorbent assayEMeradication MEASURESESemergency slaughteredEURLEuropean Union Reference LaboratoryEUSREuropean summary reportFSfallen stockH‐BSEH‐type bovine spongiform encephalopathyIHCimmunohistochemistryHShealthy slaughteredL‐BSEL‐type bovine spongiform encephalopathyMSMember StateNRLNational Reference LaboratoriesNSHCnot slaughtered for human consumptionNSPNational Scrapie PlanNUTSNomenclature of Units for Territorial StatisticsOIEWorld Organisation for Animal HealthSHCslaughtered for human consumptionSAFscrapie‐associated fibrilsSUBSE suspectTSEtransmissible spongiform encephalopathyWBWestern Blot

Country codes {#efs25069-sec-0025}
=============

AustriaATBelgiumBEBulgariaBGCroatiaHRCyprusCYCzech RepublicCZDenmarkDKEstoniaEEFinlandFIFranceFRGermanyDEGreeceELHungaryHUIcelandISIrelandIEItalyITLatviaLVLithuaniaLTLuxembourgLUMaltaMTNetherlandsNLNorwayNOPolandPLPortugalPTRomaniaROSlovakiaSKSloveniaSISpainESSwedenSESwitzerlandCHUnited KingdomUK

MS countries: AT;BE;BG;HR;CY;CZ;DK;EE;FI;FR;DE;EL;HU;IE;IT;LV;LT;LU;MT;NL;PL;PT;RO;SK;SI;ES;SE;UK.

EFTA Countries (non‐MS countries): CH (including Lichtenstein); IS; NO.

Appendix A -- Number of tested bovine animals by country, age group and different surveillance target groups in EU Member States and EFTA‐reporting countries during 2016 {#efs25069-sec-1001}
=========================================================================================================================================================================

 {#efs25069-sec-0026}

###### 

Bovine animals tested by age group in the EU Member States and EFTA reporting countries during 2016

  EU/EFTA group   Country code   Age group (months)   Total                                                                                                                                
  --------------- -------------- -------------------- -------- -------- -------- --------- --------- --------- --------- -------- --------- -------- -------- -------- --------- --------- -----------
  **EU**          **AT**         0                    303      316      632      2,986     3,179     2,922     2,533     1,995    1,461     1,097    776      571      1,143     0         19,914
  **BE**          4              6                    6        18       7,424    6,043     4,609     3,076     1,819     1,100    580       364      205      321      261       25,836    
  **BG**          0              287                  4,335    2,583    2,391    2,046     1,624     1,557     1,157     1,023    1,139     805      598      1,313    0         20,858    
  **CY**          0              0                    0        1        217      213       168       121       95        43       20        20       10       8        0         916       
  **CZ**          11             712                  557      1,121    3,131    2,710     1,995     1,441     1,051     776      490       378      256      887      0         15,516    
  **DE**          157            162                  201      842      39,063   37,034    28,871    20,155    13,150    7,928    4,870     2,839    1,830    4,204    79        161,385   
  **DK**          17             0                    4        34       6,821    5,472     3,673     2,014     1,025     533      311       192      116      357      127       20,696    
  **EE**          0              0                    1        15       1,055    944       669       393       228       120      84        25       16       23       0         3,573     
  **EL**          6              5                    75       110      287      263       2,323     1,998     1,529     1,152    790       649      579      2,335    4         12,105    
  **ES**          4              1                    9        13       12,018   10,517    8,286     6,319     4,752     3,472    2,500     2,089    2,116    10,723   0         62,819    
  **FI**          4              2                    3        13       3,035    2,891     2,132     1,272     680       403      240       173      132      250      4         11,234    
  **FR**          325            529                  1,160    4,247    40,136   37,125    30,847    24,066    18,723    13,920   10,542    8,106    6,118    56,092   4,224     256,160   
  **HR**          33             397                  1,155    1,982    2,560    2,204     2,188     1,989     1,340     1,089    814       754      523      1,158    425       18,611    
  **HU**          34             1,261                950      2,354    2,203    1,792     1,294     856       569       399      399       305      263      895      0         13,574    
  **IE**          33             24                   35       218      9,042    8,221     7,593     7,142     6,039     5,213    4,353     3,447    2,442    5,563    0         59,365    
  **IT**          12             11                   108      130      13,926   11,780    8,665     5,985     4,067     2,704    1,660     1,112    768      1,915    2         52,845    
  **LT**          0              0                    0        0        764      544       496       371       288       234      150       120      78       125      0         3,170     
  **LU**          0              0                    0        0        562      549       431       287       196       130      87        41       40       87       0         2,410     
  **LV**          26             303                  258      464      515      380       313       239       196       128      68        35       30       29       0         2,984     
  **MT**          0              0                    0        1        43       40        38        14        20        12       4         1        2        0        0         175       
  **NL**          20             38                   53       270      11,283   12,625    10,499    8,014     5,077     2,939    1,639     911      497      735      288       54,888    
  **PL**          5              2                    2        4        8,132    7,140     5,951     4,600     3,427     39,769   31,214    23,529   15,172   30,240   0         169,187   
  **PT**          0              0                    1        0        2,926    2,483     2,271     1,859     1,439     1,230    1,070     713      729      4,958    0         19,679    
  **RO**          281            399                  12,340   20,452   17,456   14,666    13,312    12,196    11,390    11,119   11,566    11,463   8,225    30,006   0         174,871   
  **SE**          33             94                   137      617      1,914    1,977     1,628     1,019     554       290      196       145      88       255      13        8,960     
  **SI**          8              14                   57       26       1,176    1,161     1,013     847       637       413      267       196      135      289      0         6,239     
  **SK**          1              616                  643      1,300    1,358    1,037     817       602       363       300      212       149      77       199      0         7,674     
  **UK**          2              78                   161      797      25,605   24,389    21,223    17,935    13,850    10,361   7,899     5,904    4,779    13,720   235       146,938   
                  Total          1,016                5,244    22,567   38,244   218,029   199,425   165,851   128,900   95,656   108,261   84,261   65,241   46,395   167,830   5,662     1,352,582
  **EFTA**        **CH**         12                   30       50       384      1,607     1,977     1,966     1,743     1,301    882       597      392      319      368       0         11,628
  **IS**          1              0                    0        1        22       4         6         28        16        49       8         4        0        0        1         140       
  **NO**          14             27                   26       137      2,004    1,783     1,203     713       404       207      92        67       43       62       145       6,927     
  Total           27             57                   76       522      3,633    3,764     3,175     2,484     1,721     1,138    697       463      362      430      146       18,695    
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###### 

Bovine animals at risk (animals with clinical signs at *ante‐mortem*, animals culled under BSE eradication measures, emergency slaughtered and fallen stock) tested by age group in EU Member States and in EFTA‐reporting countries during 2016

  EU/EFTA group   Country code   Age group (months)   Total                                                                                                                            
  --------------- -------------- -------------------- ------- ------- -------- --------- --------- --------- --------- -------- -------- -------- -------- -------- -------- --------- ---------
  **EU**          **AT**         0                    302     177     276      2,534     2,745     2,499     2,136     1,730    1,238    903      607      457      940      0         16,544
  **BE**          2              2                    5       15      7,414    6,036     4,607     3,070     1,813     1,076    579      363      205      321      259      25,767    
  **BG**          0              287                  278     217     215      175       177       177       159       146      147      93       86       155      0        2,312     
  **CY**          0              0                    0       1       217      213       168       121       95        43       20       20       10       8        0        916       
  **CZ**          5              712                  556     1,120   3,130    2,709     1,994     1,438     1,048     773      487      373      253      880      0        15,478    
  **DE**          106            155                  198     829     38,862   36,857    28,710    20,052    13,073    7,869    4,833    2,811    1,818    4,137    78       160,388   
  **DK**          16             0                    3       32      6,817    5,469     3,671     2,011     1,023     532      311      192      115      355      127      20,674    
  **EE**          0              0                    1       15      1,055    944       669       393       228       120      84       25       16       23       0        3,573     
  **EL**          2              2                    7       36      246      241       479       407       281       205      165      124      127      521      3        2,846     
  **ES**          2              0                    6       10      11,982   10,479    8,254     6,297     4,739     3,454    2,489    2,084    2,112    10,606   0        62,514    
  **FI**          4              2                    3       13      3,035    2,891     2,132     1,271     680       403      240      173      131      248      4        11,230    
  **FR**          253            512                  1,144   4,203   39,545   36,617    30,438    23,762    18,476    13,728   10,404   8,005    6,040    17,561   3,873    214,561   
  **HR**          25             379                  246     485     1,059    881       817       741       475       335      214      166      114      246      100      6,283     
  **HU**          32             1,259                886     2,210   2,058    1,688     1,176     753       460       305      266      164      142      468      0        11,867    
  **IE**          33             24                   35      218     9,042    8,221     7,593     7,142     6,039     5,213    4,353    3,447    2,442    5,563    0        59,365    
  **IT**          11             11                   16      65      13,899   11,745    8,636     5,953     4,015     2,597    1,610    1,072    746      1,870    2        52,248    
  **LT**          0              0                    0       0       764      544       496       371       288       234      150      120      78       125      0        3,170     
  **LU**          0              0                    0       0       561      549       431       287       195       130      87       41       40       87       0        2,408     
  **LV**          25             303                  258     464     515      380       312       238       196       128      68       35       30       29       0        2,981     
  **MT**          0              0                    0       1       43       39        38        14        20        12       4        1        2        0        0        174       
  **NL**          20             38                   53      270     11,278   12,622    10,498    8,013     5,075     2,939    1,638    911      496      734      282      54,867    
  **PL**          1              0                    0       1       8,129    7,139     5,950     4,600     3,425     2,553    1,862    1,263    859      1,560    0        37,342    
  **PT**          0              0                    0       0       2,926    2,483     2,154     1,766     1,366     1,174    1,029    682      699      4,796    0        19,075    
  **RO**          60             376                  362     624     608      447       456       348       294       259      242      238      168      597      0        5,079     
  **SE**          33             94                   137     616     1,914    1,977     1,628     1,019     554       289      196      145      88       255      12       8,957     
  **SI**          5              13                   5       14      1,172    1,159     1,013     842       634       411      265      195      134      285      0        6,147     
  **SK**          1              616                  643     1,300   1,358    1,037     817       602       363       300      212      149      77       199      0        7,674     
  **UK**          2              78                   161     796     25,598   24,383    21,223    17,935    13,847    10,361   7,899    5,904    4,779    13,720   235      146,920   
                  Total          638                  5,165   5,180   13,831   195,976   180,670   147,036   111,759   80,591   56,827   40,757   29,403   22,264   66,289   4,975     961,370
  **EFTA**        **CH**         12                   29      50      379      1,600     1,977     1,956     1,737     1,300    878      596      392      319      368      0         11,593
  **IS**          1              0                    0       1       0        4         3         1         1         0        1        0        0        0        1        13        
  **NO**          14             27                   26      136     2,004    1,783     1,203     713       404       207      92       67       43       62       145      6,926     
  Total           27             56                   76      516     3,604    3,764     3,162     2,451     1,705     1,085    689      459      362      430      146      18,532    
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###### 

Healthy slaughtered bovine animals tested by age group in EU Member States and in EFTA‐reporting countries during 2016

  EU/EFTA group   Country code   Age group (months)   Total                                                                                                                                                                                             
  --------------- -------------- -------------------- ------- -------- --------- ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------- --------- -------------
  **EU**          **AT**         0                    0       0        0         138          355          450          431          422          395          263          223          194          169          114          201           0         3,355
  **BE**          0              0                    0       0        1         1            4            2            1            2            4            24           1            0            0            0            2             42        
  **BG**          0              0                    0       0        4,057     2,366        2,176        1,871        1,447        1,380        998          877          992          712          512          1,158        0             18,546    
  **CY**          0              0                    0       0        0         0            0            0            0            0            0            0            0            0            0            0            0             0         
  **CZ**          6              0                    0       0        1         1            0            0            1            3            3            3            3            5            3            7            0             36        
  **DE**          51             0                    0       7        3         10           95           87           77           54           35           29           22           18           6            41           1             536       
  **DK**          1              0                    0       0        1         2            4            3            2            3            2            1            0            0            0            2            0             21        
  **EE**          0              0                    0       0        0         0            0            0            0            0            0            0            0            0            0            0            0             0         
  **EL**          4              0                    0       3        68        74           40           21           1,844        1,590        1,247        945          625          525          452          1,814        1             9,253     
  **ES**          1              0                    0       1        3         3            36           38           32           22           13           18           11           4            4            116          0             302       
  **FI**          0              0                    0       0        0         0            0            0            0            1            0            0            0            0            1            2            0             4         
  **FR**          72             0                    0       17       15        44           591          507          408          304          247          191          137          101          78           38,531       351           41,594    
  **HR**          7              0                    0       18       909       1,497        1,501        1,323        1,371        1,248        865          754          600          588          409          912          325           12,327    
  **HU**          2              0                    0       2        64        144          145          104          118          103          109          93           133          141          120          427          0             1,705     
  **IE**          0              0                    0       0        0         0            0            0            0            0            0            0            0            0            0            0            0             0         
  **IT**          1              0                    92      65       27        35           29           32           52           107          50           40           22           45           0            0            0             597       
  **LT**          0              0                    0       0        0         0            0            0            0            0            0            0            0            0            0            0            0             0         
  **LU**          0              0                    0       0        0         0            0            0            0            0            0            0            0            0            0            0            0             0         
  **LV**          0              0                    0       0        0         0            0            0            0            0            0            0            0            0            0            0            0             0         
  **MT**          0              0                    0       0        0         0            0            0            0            0            0            0            0            0            0            0            0             0         
  **NL**          0              0                    0       0        0         0            5            3            1            1            2            0            1            0            1            1            6             21        
  **PL**          0              0                    0       0        0         0            0            0            0            0            1            37,216       29,350       22,266       14,312       28,680       0             131,825   
  **PT**          0              0                    0       0        0         0            0            0            117          93           73           56           41           31           30           162          0             603       
  **RO**          213            0                    0       19       11,876    19,824       16,842       14,217       12,852       11,846       11,090       10,857       11,322       11,220       8,052        29,392       0             169,722   
  **SE**          0              0                    0       0        0         0            0            0            0            0            0            0            0            0            0            0            1             1         
  **SI**          0              0                    0       0        51        9            2            2            0            4            2            1            2            1            1            4            0             79        
  **SK**          0              0                    0       0        0         0            0            0            0            0            0            0            0            0            0            0            0             0         
  **UK**          0              0                    0       0        0         1            8            6            0            0            2            0            0            0            0            0            0             17        
                  Total          **358**              **0**   **92**   **132**   **17,314**   **24,366**   **21,928**   **18,647**   **18,745**   **17,156**   **15,006**   **51,328**   **43,456**   **35,826**   **24,095**   **101,450**   **687**   **390,586**
  **EFTA**        **CH**         0                    0       0        0         0            0            0            0            0            0            0            0            0            0            0            0             0         0
  **IS**          0              0                    0       0        0         0            22           0            3            27           15           49           7            4            0            0            0             127       
  **NO**          0              0                    0       0        0         0            1            0            0            0            0            0            0            0            0            0            0             1         
  Total           **0**          **0**                **0**   **0**    **0**     **0**        **23**       **0**        **3**        **27**       **15**       **49**       **7**        **4**        **0**        **0**        **0**         **128**   
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###### 

BSE suspected bovine animals tested by age group in EU Member States and in EFTA‐reporting countries during 2016

  EU/EFTA group   Country code   Age group (months)   Total                                                                       
  --------------- -------------- -------------------- ------- --- ----- ----- ----- ---- ---- ---- ---- ---- ---- ---- ---- ----- -----
  **EU**          **AT**         0                    1       1   1     2     3     1    2    2    0    0    0    0    2    0     15
  **BE**          2              4                    0       2   6     5     1     4    2    0    0    1    0    0    0    27    
  **BG**          0              0                    0       0   0     0     0     0    0    0    0    0    0    0    0    0     
  **CY**          0              0                    0       0   0     0     0     0    0    0    0    0    0    0    0    0     
  **CZ**          0              0                    0       0   1     1     0     0    0    0    0    0    0    0    0    2     
  **DE**          0              0                    0       3   106   90    84    49   42   30   15   10   6    26   0    461   
  **DK**          0              0                    0       0   0     0     0     0    0    0    0    0    1    0    0    1     
  **EE**          0              0                    0       0   0     0     0     0    0    0    0    0    0    0    0    0     
  **EL**          0              0                    0       0   1     1     0     1    1    2    0    0    0    0    0    6     
  **ES**          1              0                    0       0   0     0     0     0    0    0    0    1    0    1    0    3     
  **FI**          0              0                    0       0   0     0     0     0    0    0    0    0    0    0    0    0     
  **FR**          0              0                    1       0   0     1     1     0    0    1    1    0    0    0    0    5     
  **HR**          1              0                    0       0   0     0     0     0    0    0    0    0    0    0    0    1     
  **HU**          0              0                    0       0   0     0     0     0    0    1    0    0    1    0    0    2     
  **IE**          0              0                    0       0   0     0     0     0    0    0    0    0    0    0    0    0     
  **IT**          0              0                    0       0   0     0     0     0    0    0    0    0    0    0    0    0     
  **LT**          0              0                    0       0   0     0     0     0    0    0    0    0    0    0    0    0     
  **LU**          0              0                    0       0   1     0     0     0    1    0    0    0    0    0    0    2     
  **LV**          1              0                    0       0   0     0     1     1    0    0    0    0    0    0    0    3     
  **MT**          0              0                    0       0   0     1     0     0    0    0    0    0    0    0    0    1     
  **NL**          0              0                    0       0   0     0     0     0    0    0    0    0    0    0    0    0     
  **PL**          4              2                    2       3   3     1     1     0    1    0    2    0    1    0    0    20    
  **PT**          0              0                    1       0   0     0     0     0    0    0    0    0    0    0    0    1     
  **RO**          8              4                    2       4   6     2     4     2    6    3    2    5    5    17   0    70    
  **SE**          0              0                    0       1   0     0     0     0    0    1    0    0    0    0    0    2     
  **SI**          3              1                    1       3   2     0     0     1    1    1    0    0    0    0    0    13    
  **SK**          0              0                    0       0   0     0     0     0    0    0    0    0    0    0    0    0     
  **UK**          0              0                    0       0   0     0     0     0    1    0    0    0    0    0    0    1     
                  Total          20                   12      8   17    128   105   93   60   57   39   20   17   14   46   0     636
  **EFTA**        **CH**         0                    1       0   5     7     0     10   6    1    4    1    0    0    0    0     35
  **IS**          0              0                    0       0   0     0     0     0    0    0    0    0    0    0    0    0     
  **NO**          0              0                    0       0   0     0     0     0    0    0    0    0    0    0    0    0     
  Total           0              1                    0       5   7     0     10    6    1    4    1    0    0    0    0    35    
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###### 

BSE active monitoring in relation to the adult bovine population (age \> 2 years) during 2016

  EU/EFTA group                                    Country code   Adult cattle (\> 2 years)[a](#efs25069-note-0055){ref-type="fn"}   Number of tested bovine animals at risk[b](#efs25069-note-0056){ref-type="fn"}   Proportion (%) of tested bovine animals at risk[b](#efs25069-note-0056){ref-type="fn"}
  ------------------------------------------------ -------------- ------------------------------------------------------------------ -------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------
  **EU**                                           **AT**         894,050                                                            16,544                                                                           1.85
  **BE**                                           1,261,350      25,767                                                             2.04                                                                             
  **BG**                                           388,240        2,312                                                              0.60                                                                             
  **CY**                                           28,720         916                                                                3.19                                                                             
  **CZ**                                           653,700        15,478                                                             2.37                                                                             
  **DE**                                           5,805,970      160,388                                                            2.76                                                                             
  **DK**                                           726,000        20,674                                                             2.85                                                                             
  **EE**                                           133,300        3,573                                                              2.68                                                                             
  **EL**                                           325,000        2,846                                                              0.88                                                                             
  **ES**                                           3,071,890      62,514                                                             2.04                                                                             
  **FI**                                           374,280        11,230                                                             3.00                                                                             
  **FR**                                           10,327,000     214,561                                                            2.08                                                                             
  **HR**                                           219,000        6,283                                                              2.87                                                                             
  **HU**                                           421,000        11,867                                                             2.82                                                                             
  **IE**                                           2,736,570      59,365                                                             2.17                                                                             
  **IT**                                           3,098,580      52,248                                                             1.69                                                                             
  **LT**                                           385,400        3,170                                                              0.82                                                                             
  **LU**                                           102,330        2,408                                                              2.35                                                                             
  **LV**                                           229,320        2,981                                                              1.30                                                                             
  **MT**                                           7,200          174                                                                2.42                                                                             
  **NL**                                           1,948,000      54,867                                                             2.82                                                                             
  **PL**                                           2,614,090      37,342                                                             1.43                                                                             
  **PT**                                           855,800        19,075                                                             2.23                                                                             
  **RO**                                           1,356,500      5,079                                                              0.37                                                                             
  **SE**                                           619,010        8,957                                                              1.45                                                                             
  **SI**                                           202,310        6,147                                                              3.04                                                                             
  **SK**                                           236,330        7,674                                                              3.25                                                                             
  **UK**                                           4,477,000      146,920                                                            3.28                                                                             
                                                   Total          43,497,940                                                         961,350                                                                          2.21
  **EFTA**                                         **CH**         812,880                                                            11,593                                                                           1.43
  **IS**                                           34,200         13                                                                 0.04                                                                             
  **NO** [c](#efs25069-note-0057){ref-type="fn"}   353,483        6,926                                                              1.96                                                                             
  Total                                            1,200,563      18,532                                                             1.54                                                                             

NA: not applicable.

Eurostat October 2016 refers to adult cattle population reported in 2015.

At risk animals is the sum of animals with clinical signs at *ante‐mortem*, animals culled under BSE eradication measures, emergency slaughtered and fallen stock.

Norwegian data were obtained from the central Cattle register in Norway.
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Appendix B -- Evolution of the ratio of CS:AS cases in the period 2002--2016 by country {#efs25069-sec-1002}
=======================================================================================

 {#efs25069-sec-0027}

1\) Countries with a CS:AS ratio \< 1 (AT, BE, DK, EE, FI, HR, PL, PT and SE) ![](EFS2-15-e05069-g014.jpg "image")

2\) Countries with a CS:AS ratio crossing 1 at some time point (BG, the CZ, DE, FR, HU, IE, the NL, SI, SK, the UK, NO) ![](EFS2-15-e05069-g015.jpg "image")

3\) Countries with a CS:AS ratio \> 1 (CY, EL, ES, IT, RO, IS) ![](EFS2-15-e05069-g016.jpg "image")

Appendix C -- Cumulative geographical distribution of numbers of cases of: C‐BSE (A); C‐BSE restricted to BARB cases (B); H‐BSE (C); and L‐BSE (D) for the period 2001--2016 {#efs25069-sec-1003}
============================================================================================================================================================================

 {#efs25069-sec-0028}
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Appendix D -- Geographical distribution and numbers of cases of: ovine CS (A); caprine CS (B); ovine AS (C); and caprine AS (D) in 2016 {#efs25069-sec-1004}
=======================================================================================================================================

 {#efs25069-sec-0029}
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